EurekaMag PDF full texts Chapter 35,999

Orman, K.L.; English, B.K. 2000: Tyrosine kinase inhibitors decrease inducible nitric oxide synthase and tumor necrosis factor production in raw 2647 macrophages stimulated with Streptococcus pneumoniae. Journal of Investigative Medicine 48(1): 147A

Gallick, G.E. 2000: Tyrosine kinase inhibitors for suppression of tumorigenic growth of Ras-transformed cells: PAK-ing in the signals. Cancer Journal 6(4): 217-219

Sawyers, C.L.; Druker, B. 1999: Tyrosine kinase inhibitors in chronic myeloid leukemia. Cancer Journal from Scientific American 5(2): 63-69

Drummond, M.W.; Holyoake, T.L. 2001: Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?. Blood Reviews 15(2): 85-95

McHugh, L.A.; Griffiths, T.R.L.; Kriajevska, M.; Symonds, R.P.; Mellon, J.K. 2004: Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancer. Urology 63(4): 619-624

Murray, P.T.; Salvi, D.; Umans, J.G. 1999: Tyrosine kinase inhibitors prevent endotoxin-induced impairment of vasodilator agonist-stimulated endothelial calcium mobilization. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 398A

Wang, J.; Zhang, L.; Wu, J.; Talpaz, M.; Donato, N.J. 2002: Tyrosine kinase inhibitors regulate TRAIL-sensitivity in non-small cell lung cancer cells Evidence for a novel target. Proceedings of the American Association for Cancer Research Annual Meeting 43: 411

Noonberg, S.B.; Benz, C.C. 2000: Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents. Drugs 59(4): 753-767

Aoki, K.; Williams, R.B.; Lewis, A.I.; Parent, A.D.; Zhang, J. 1999: Tyrosine kinase mediates ATP-induced CA2+ mobilization in rat basilar smooth muscle cells. FASEB Journal 13(4 Part 1): A136

Kline, L.W. 2002: Tyrosine kinase mediates part of the progesterone -induced relaxation of Guinea pig gallbladder strips. FASEB Journal 16(5): A870

Young, J.S.; Dueitt, B.; Falcone, J.C.; Dholakia, J.N.; Joshua, I.G.; Passmore, J.C. 2003: Tyrosine kinase mediation of various isotypes of alpha-adrenergic vascular constriction. FASEB Journal 17(4-5): Abstract 587

Oparil, S.; Sun, J.Z.; Lucchesi, P.; Chen, Y.F. 2001: Tyrosine kinase receptor activation, but not hypoxia, inhibits atrial natriuretic peptide clearance receptor expression in pulmonary arterial smooth muscle cells. Journal of the American College of Cardiology 37(2 Suppl A): 225A

Valenzuela, D.M.; Glass, D.J.; Bowen, D.C.; Yancopoulos, G.D. 2002: Tyrosine kinase receptors and ligands. Official Gazette of the United States Patent and Trademark Office Patents 1260(1)

Marme, D. 2001: Tyrosine kinase receptors as target for anti-angiogenic approaches. European Journal of Cancer 37(Suppl 6): S255

Okada, M. 2000: Tyrosine kinase signaling in the membrane microdomain. Cell Structure and Function 25(6): 406

Grosios, K.; Traxler, P. 2003: Tyrosine kinase targets in drug discovery. Drugs of the Future 28(7): 679-697

Hill, M.A.; Potocnik, S.J.; Martinez Lemus, L.A.; Meininger, G.A. 2003: Tyrosine kinase, but not Rho kinase, inhibition prevents prolonged norepinephrine exposure-induced changes in relaxation. FASEB Journal 17(4-5): Abstract 102

Rao, R.K.; Karnaky, K.J.Jr 2002: Tyrosine kinase-dependent dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton during oxidative stress-induced disruption of tight junction. Gastroenterology 122(4 Suppl 1): A-405

Schneck, A.C.; Bosch, R.F.; Kuehlkamp, V. 2002: Tyrosine kinase-dependent inhibition of the slow delayed rectifier K+ current IKs by beta3-adrenergic activation in guinea pig ventricular myocytes. Pfluegers Archiv European Journal of Physiology 443(Suppl 1): S277

Okubo, S.; Tanabe, Y.; Satho, R.; Hoshiba, Y.; Takeda, K.; Kitayama, M.; Kanemitsu, S.; Tsugawa, H.; Takekoshi, N. 2004: Tyrosine kinase-dependent mechanism occurs downstream of protein kinase C activation in the pharmacological preconditioning by alpha-1 adrenoceptor stimulation. Journal of the American College of Cardiology 43(5 Suppl A): 245A

Wei, L.; Yang, Y.; Yu, Q. 2001: Tyrosine kinase-dependent, PI 3K and MAPK-independent signaling pathways prevent lung tumor cells from Anoikis. FASEB Journal 15(4): A508

Kim, Y.H.; Koh, J.Y. 1999: Tyrosine kinase-linked membrane receptors may mediate the non-proteolytic protective action of tPA against zinc toxicity in cortical culture. Society for Neuroscience Abstracts 25(1-2): 324

Tan, C.M.; Feldman, R.D. 1999: Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase Involvement of multiple serine residues in the catalytic region. FASEB Journal 13(5 Part 2): A791

Wu, J.Y.; Talpaz, M.; Donato, N.J. 2003: Tyrosine kinases and phosphatases play a role in STI571- mediate apoptosis of chronic myelogenous leukemia cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 205

Ochoa-de la Paz, L.D.; Lezama, R.A. 2003: Tyrosine kinases and taurine release: signaling events and amino acid release under hyposmotic and ischemic conditions in the chicken retina. Advances in Experimental Medicine and Biology 526: 493-498

Malpica, A.; Broaddus, R.; Deavers, M.T.; Kavanagh, J.; Silva, E.G. 2003: Tyrosine kinases in ovarian dysgerminoma. Modern Pathology 16(1): 200A

Hewins, P.; Williams, J.M.; Wakelam, M.J.; Savage, C.O.S. 2003: Tyrosine kinases in the activation of neutrophils by ANCA. Kidney and Blood Pressure Research 26(4): 265-266

Schroder, F.; Klein, G.; Frank, T.; Bastein, M.; Drexler, H. 2003: Tyrosine kinases inhibit availability and open probability of single L-type calcium channels in human atrial myocytes. Journal of the American College of Cardiology 41(6 Suppl A): 90A

Graves, D.; Rosado, J.A.; Sage, S.O. 2000: Tyrosine kinases mediate store-regulated Ca2+ entry by remodelling of the actin cytoskeleton in human platelets. Journal of Physiology (Cambridge) 527P: 79P-80P

Purcell, A.L.; Carew, T.J. 1999: Tyrosine kinases modulate serotonin-induced excitability in Aplysia sensory neurons. Society for Neuroscience Abstracts 25(1-2): 863

Boixel, C.; Mercadier, J.J.; Hatem, S. 1999: Tyrosine kinases suppress the L-type calcium current in human atrial myocytes. Journal of Molecular and Cellular Cardiology 31(6): A65

Gaudry, C.A.; Denning, M.F.; Palka, H.L.; Park, J.K.; Hudson, L.G.; Green, K.J. 2000: Tyrosine kinases target desmosomal proteins and inhibit desmoplakin Plakoglobin interactions. Journal of Investigative Dermatology 114(4): 766

Bongiovanni, R.; Simpson, C.; Yamamoto, B.K.; Jaskiw, G.E. 1999: Tyrosine levels in serum, brain tissue and brain microdialysate after tyrosine administration to the rat. Society for Neuroscience Abstracts 25(1-2): 716

Wu, G.S.; Lee, T.D.; Rao, N.A. 2001: Tyrosine moieties of rod outer segment proteins are nitrated by peroxynitrite generated in vitro. IOVS Investigative Ophthalmology and Visual Science 42(4): S192

Carmines, P.K.; Pollock, J.S.; Ishii, N.; Patel, K.P.; Lane, P.H.; Bian, K.; Murad, F. 1999: Tyrosine nitration accompanies increased nitric oxide and superoxide anion production in renal cortex during the hyperfiltration stage of diabetes mellitus. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 393A

Kagan, E.; Iwagaki, A.; Choe, N.; Zhang, P.; Wang, Y.Z.; Bonner, J.C. 2001: Tyrosine nitration and mitogen-activated protein kinase activation in asbestosis-induced pulmonary fibrosis. Chest 120(1 Suppl): 26S-27S

Katsuki, H.; Akaike, A. 2004: Tyrosine nitration and neurodegenerative disorders. Journal of Pharmacological Sciences 94(Suppl 1): 48P

Fukuyama, N.; Ichimori, K.; Delophon, P.; Nakazawa, H.; Kameoka, Y.; Ohashi, Y.; Kohi, F.; Suzuki, K. 2000: Tyrosine nitration by MPO-deficient human neutrophils. Nitric Oxide 4(3): 222

Amengual, C.; Suarez, E.; Alvarez, B.; Denicola, A. 2003: Tyrosine nitration by peroxidases Effect of bicarbonate and glutathione. Free Radical Biology and Medicine 35(Suppl 1): S93-S94

Sawa, T.; Akaike, T.; Maeda, H. 1999: Tyrosine nitration by peroxynitrite generated from xanthine oxidase-hypoxathine and nitric oxide. Acta Physiologica Scandinavica 167(Suppl 645): 84

Estevez, A. 2003: Tyrosine nitration by peroxynitrite in motor neurons. Free Radical Biology and Medicine 35(Suppl 1): S156

Shanbhag, P.P.; Shanbhag, V.P.; Kreahling, J.M.; Morgan, R.; Kuo, W.N. 2002: Tyrosine nitration in proteins/enzymes. Abstracts of Papers American Chemical Society 223(1-2): CHED 395

Pfeiffer, S.; Schmidt, K.; Mayer, B. 1999: Tyrosine nitration is negligible at low peroxynitrite steady-state levels. Free Radical Biology and Medicine 27(Suppl 1): S84

Horwitz, J.; Ara, J.; Ischiropoulos, H. 1999: Tyrosine nitration leads to decreased tyrosine hydroxylase levels via proteosomal degradation pathway. Society for Neuroscience Abstracts 25(1-2): 1340

Carreras, M.C.; Riobo, N.A.; Converso, D.; Baredes, N.; Del Bosco, C.G.; Poderoso, J.J. 2000: Tyrosine nitration of plasma proteins and polymorphonuclear cells in the progression of human sepsis. Nitric Oxide 4(3): 296

Yamada, K.; Tran, M.H.; Nakajima, A.; Mizuno, M.; Kamei, H.; Nabeshima, T. 2002: Tyrosine nitrosylation of synaptophysin induced by amyloid beta-protein. Japanese Journal of Pharmacology 88(Suppl 1): 93P

Allen, J.P.; Kalman, L.; Narvaez, A.J.; Lobrutto, R.; Williams, J.C. 2001: Tyrosine oxidation in modified reaction centers from Rhodobacter sphaeroides. Photosynthesis Research 69(1-3): 73-74

Poindexter, B.B.; Wright Coltart, S.; Leitch, C.A.; Denne, S.C. 2001: Tyrosine oxidation in response to parenteral nutrition in premature neonates. Pediatric Research 49(4 Part 2): 349A

Papisova, A.I.; Bazhulina, N.P.; Faleev, N.G.; Demidkina, T.V. 2003: Tyrosine phenol-lyase Catalytic role of the cofactor-binding serine 254. Doklady Akademii Nauk 391(5): 696-700

Qin, S.; Chock, P.B. 2002: Tyrosine phosphatase CD45 regulates hydrogen peroxide-induced calcium mobilization in B cells. Antioxidants and Redox Signaling 4(3): 481-490

Okenwa, C.; Rego, D.; Pang, N.J.; Kozlowski, M. 2003: Tyrosine phosphatase SHP-1 regulates LPS-induced cytokine networks involved in inflammation. Cellular and Molecular Biology Letters 8(2A): 590-591

Kozlowski, M.; Yang, H.; Lee, F.; Zoueva, O.; Ridsdale, A.; Graziani Bowering, G.; Kumar, A. 1999: Tyrosine phosphatase SHP-1 regulates cytoskeletal proteins in murine macrophages Lack of SHP-1 leads to degranulation of cytoskeletal organization in macrophages of motheaten mice. Cytokine 11(11): 935

Ceryak, S.M.; Zingariello, C.; Brand, A.; Ha, L.; Patierno, S.R. 2003: Tyrosine phosphatase inhibition abrogates both genotoxin-induced growth arrest and AKT down-regulation. Proceedings of the American Association for Cancer Research Annual Meeting 44: 401

Zhao, X.; Madhavan, R.; Luo, X.; Peng, H.B. 2004: Tyrosine phosphatase regulation of MuSK-dependent ACh receptor clustering. Journal of Neurochemistry 88(Suppl 1): 84

Haier, J.; Nasralla, M.; Nicolson, G.L. 1999: Tyrosine phosphatases in integrin-mediated cell adhesion to collagen under static and dynamic flow conditions. European Journal of Cancer 35(Suppl 4): S77

Alexander, D.R. 1999: Tyrosine phosphatases regulate receptor thresholds in T cell apoptosis, signalling and development. Immunology 98(Suppl 1): 53

Delisser, H.M.; Cao, G.; O'brien, C.D. 2003: Tyrosine phosphorylated PECAM-1, via recruitment of SHP-2, promotes cell motility. FASEB Journal 17(4-5): Abstract 418

Lasky, L.A. 2000: Tyrosine phosphorylated cleavage furrow-associated proteins. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)

Khurana, S.; Bae, Y.S.o 1999: Tyrosine phosphorylated villin binds to the COOH-terminal SH2 domain of phospholipase C-gamma1. Gastroenterology 116(4 Part 2): A616

Hirsch, J.R.; Rossmuller, N.; Schlatter, E. 2001: Tyrosine phosphorylation A novel pathway for natriuretic peptides in the kidney?. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 568A

Albert, A.P.; Aromolaran, A.S.; Large, W.A. 1999: Tyrosine phosphorylation activates a non-selective cation current in rabbit portal vein myocytes. Journal of Physiology (Cambridge) 521P: 58P-59P

Murphy, T.V.; Spurrell, B.E.; Hill, M.A. 1999: Tyrosine phosphorylation and myogenic responses in arterioles. British Journal of Pharmacology 127(Proceedings Suppl ): 3P

Choudhury, Goutam Ghosh 2002: Tyrosine phosphorylation and phosphatidylinositol 3 kinase /Akt signal transduction regulate TGFbeta-induced fibronectin gene expression in mesangial cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 311A

Hayashi, T.; Huganir, R.L. 2004: Tyrosine phosphorylation and regulation of the AMPA receptor by SRC family tyrosine kinases. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(27): 6152-6160

Sen, I.; Sadhukhan, R.; Santhamma, K.R. 1999: Tyrosine phosphorylation and the cleavage and secretion of angiotensin-converting enzyme. Cytokine 11(11): 921

Naffah Mazzacoratti, M.G.; Arganaraz, G.A.; Funke, M.G.; Porcionatto, M.A.; Scorza, F.A.; Silva, R.; Amado, D.; Nader, H.B.; Cavalheiro, E.A. 1999: Tyrosine phosphorylation and the receptor of protein tyrosine phosphatase beta expression are increased in the rat hippocampus during the epileptic phenomena. Epilepsia 40(Suppl 2): 149

Larouche, M.; Bulloch, A.G.M. 1999: Tyrosine phosphorylation in Lymnaea neurons Role in neurite outgrowth. Society for Neuroscience Abstracts 25(1-2): 2276

Hunter, T. 2002: Tyrosine phosphorylation in cell signaling and disease. Keio Journal of Medicine 51(2): 61-71

Bhattacharya, S.; Patel, R.; Bhattacharya, J. 1999: Tyrosine phosphorylation in freshly isolated lung endothelial cells. FASEB Journal 13(7): A1580

Haralambieva, E.; Jones, M.; Roncador, G.M.; Cerroni, L.; Lamant, L.; Ott, G.; Rosenwald, A.; Sherman, C.; Thorner, P.; Kusec, R.; Wood, K.M.; Campo, E.; Falini, B.; Ramsay, A.; Marafioti, T.; Stein, H.; Kluin, P.M.; Pulford, K.; Mason, D.Y. 2003: Tyrosine phosphorylation in human lymphomas. Histochemical Journal 34(11-12): 545-552

Hamilton, G.; Ulsperger, E.; Haberl, I.; Raderer, M.; Hoffmann, O. 1999: Tyrosine phosphorylation in osteoblast-like MC3T3-E1 cells in response O carcinoma cell line supernatants. British Journal of Cancer 80(Suppl 2): 72

Furspan, P.; Freedman, R.R. 2003: Tyrosine phosphorylation in skin arterioles from subjects with Raynauds disease. FASEB Journal 17(4-5): Abstract

Bhattacharya, R.; Patel, R.; Bhattacharya, S. 1999: Tyrosine phosphorylation increases electrical resistance of lung endothelial monolayers. FASEB Journal 13(4 Part 1): A501

Lopez, J.P.; Shepherd, V.L. 1999: Tyrosine phosphorylation is involved in SP-A/mycobacterium-induced signaling in rat macrophages. FASEB Journal 13(4 Part 1): A196

Shigemoto, K.; Kubo, S.; Kondo, I.; Maruyama, N. 2001: Tyrosine phosphorylation is required for agrin-independent acetylcholine receptor clustering. Cell Structure and Function 26(5): 486

Deleuze, C.; Duvoid, A.; Hussy, N. 1999: Tyrosine phosphorylation modulates the osmosensitivity of taurine efflux in glial cells of the rat supraoptic nucleus. Journal of Physiology (Cambridge) 517P: 96P

Hirata, Y.; Maeda, S.; Mitsuno, Y.; Akanuma, M.; Yamaji, Y.; Ogura, K.; Yoshida, H.; Shiratori, Y.; Omata, M. 2000: Tyrosine phosphorylation of CagA of H pylori isolates in Japan. Gut 47(Suppl 1): A27

Huang, W.C.; Chen, C.C. 2003: Tyrosine phosphorylation of IKKalpha/beta by PKC-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression. FASEB Journal 17(4-5): Abstract 650

Kimura, T.; Inoue, Y.; Hisano, M.; Adachi, M. 1999: Tyrosine phosphorylation of LAT by stimulation with the high affinity IgE receptor. Journal of Allergy and Clinical Immunology 103(1 Part 2): S167

Spurrell, B.E.; Murphy, T.V.; Hill, M.A. 2001: Tyrosine phosphorylation of MAP kinase following increased intraluminal pressure or epidermal growth factor in cannulated arterioles. FASEB Journal 15(4): A43

Brodie, C.; Blass, M.; Blumberg, P.M.; Kronfeld, I. 2001: Tyrosine phosphorylation of PKCdelta is essential for the apoptosis induced by etoposide and gamma-irradiation. FASEB Journal 15(4): A546

Cheng, W.H.; Von Kobbe, C.; Opresko, P.L.; Kufe, D.; Bohr, V.A. 2003: Tyrosine phosphorylation of Werner syndrome protein by Abl kinase modulates its functions. Proceedings of the American Association for Cancer Research Annual Meeting 44: 234

Izaguirre, G.; Aguirre, L.; Aneskievich, B.; Haimovich, B. 2000: Tyrosine phosphorylation of alpha-actinin affects the cellular localization of alpha-actinin and actin. Molecular Biology of the Cell 11(Suppl): 185a-186a

Libetta, C.; Minetti, G.; Ciana, A.; Brovelli, A.; Dal Canton, A. 2000: Tyrosine phosphorylation of band 3 protein in erythrocytes of hemodialysis patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 283A

Meng, T.C.; Lin, M.F. 1999: Tyrosine phosphorylation of c-ErbB-2 regulates the androgen-responsiveness in human prostate carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 406

Weed, S.A.; Kinley, A.W.; Karginov, A.V.; Head, J.A.; Schaefer, E.M.; Parsons, J.T.omas 2001: Tyrosine phosphorylation of cortactin by c-Src requires Rac-mediated localization to the cortical actin cytoskeleton. Molecular Biology of the Cell 12(Suppl): 286a-287a

Treigyte, G.; Navakauskiene, R.; Kulyte, A.; Gineitis, A.; Magnusson, K.E. 2000: Tyrosine phosphorylation of cytosolic and nuclear proteins in HL60 cells undergoing apoptosis. Biochemical Society Transactions 28(5): A379

Rong, Y.; Lu, X.; Baudry, M. 1999: Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn and Src selectively modulates their susceptibility to calpain. Society for Neuroscience Abstracts 25(1-2): 2203

Babawale, M.O.; Lammiman, M.J.; Mayhew, T.M.; James, D.K.; Leach, L. 1999: Tyrosine phosphorylation of junctional molecules in gestational diabetes - a study of human placental microvessels. Placenta 20(5-6): A 12

Ling, S.; Braun, A. 2002: Tyrosine phosphorylation of large conductance, calcium-sensitive K+ channels in situ. Biophysical Journal 82(1 Part 2): 585a-586a

Yang, M.; Leonard, J.P. 1999: Tyrosine phosphorylation of mouse NMDA receptor NR2A by co-expression with v-Src or Fyn. Society for Neuroscience Abstracts 25(1-2): 1978

Tsubouchi, A.; Yano, H.; Sabe, H. 2001: Tyrosine phosphorylation of paxillin is important for microtubule organizing center positioning and directional persistency in motile epithelial cells. International Journal of Molecular Medicine 8(Suppl 1): S70

Fang, L.H.; Cho, K.S.; Ahn, H.Y. 1999: Tyrosine phosphorylation of paxillin may be regulated during vascular smooth muscle contraction. Biophysical Journal 76(1 Part 2): A289

Moreno Altamirano, M.M.B.; Sanchez Garcia, F.J.; Munoz Moreno, L. 2000: Tyrosine phosphorylation of several host proteins during dengue virus infection. Immunology Letters 73(2-3): 142

Moodie, S.A.; Alleman Sposeto, J.; Gustafson, T.A. 1999: Tyrosine phosphorylation of the SH2-, PH- containing adaptor protein, APS, by insulin in 3T3-L1 adipocytes. Diabetes 48(Suppl 1): A332

Jaschinski, F.; Spinas, G.A.; Trub, T. 2000: Tyrosine phosphorylation of the insulin receptor is induced by binding to insulin receptor substrates 1 and 2. Biochemical Society Transactions 28(5): A267

Snell, D.; Pasquet, J.M.; Becker, M.; Watson, S.P. 2000: Tyrosine phosphorylation of the paired immunoglobulin-like receptor B in mouse platelets and megakaryocytes. Tissue Antigens 55(Suppl 1): 90

Murphy, T.V.; Spurrell, B.E.; Hill, M.A. 2002: Tyrosine phosphorylation pathways in myogenic constriction of arterioles. FASEB Journal 16(4): A79

Brodie, C.; Blass, M.; Kronfeld, I.; Kazimirsky, G.; Blumberg, P.M. 2002: Tyrosine phosphorylation regulates the apoptotic function of PKCdelta in glioma cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 329

Henkemeyer, M. 2003: Tyrosine phosphorylation signals in axon pathfinding. Journal of Neurochemistry 85(Suppl 1): 94

Lopaczynski, W.; Miltyk, W.; Mahoney, C.; Albright, C.; Crowell, J.; Zeisel, S.H. 2001: Tyrosine phosphorylation, DNA damage and apoptosis in lymphocytes isolated from postmenopausal women and prostate cancer patients treated with a single dose of isoflavone mixture containing genistein. FASEB Journal 15(4): A600

Kumagai, H.; Suzuki, H.; Katayama, T. 2000: Tyrosine repressor gene of a bacterium belonging to the genus Erwinia. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)

Roberts, S.A.; Ball, R.O.; Moore, A.M.; Filler, R.M.; Pencharz, P.B. 1999: Tyrosine requirement in the parenterally-fed neonate. FASEB Journal 13(5 Part 2): A910

Schwab, R.; Bagrintseva, K.; Wolf, U.; Eichenlaub, S.; Hiddemann, W.; Spiekermann, K. 2003: Tyrosine residues 589/591 and 597/599 of FLT3 are critical for the transforming potential and STAT5/MAPK activation of the FLT3-TKD mutant in Ba/F3 cells. Blood 102(11): 202b

Wu, Q.; Klimchuk, E.; Likic, V.; Kemple, M.D.; Prendergast, F.G. 2000: Tyrosine side chain dynamics of rat intestinal fatty acid binding protein by 13C NMR. Biophysical Journal 78(1 Part 2): 33A

Fong, A.M.; Alam, M.; Bodduluri, H.; Imai, T.; Patel, D.D. 2001: Tyrosine sulfation of CX3CR1 is necessary for fractalkine-mediated cell capture and firm adhesion. FASEB Journal 15(4): A331

Carlow, C.K.S.; Hong, X.; Ma, D. 2000: Tyrosine-containing cyclophilin and related methods. Official Gazette of the United States Patent and Trademark Office Patents 1240(3)

Rafferty, M.F.; Song, Y. 2001: Tyrosine-derived compounds as calcium channel antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)

Schwab, R.; Schafer, E.; Varkondi, E.; Bokonyi, G.; Gyokeres, T.; Orfi, L.; Keri, G.; Pap, A. 2003: Tyrosine-kinase bioassay platform for screening inhibitory compound-libraries targeting pancreatic cancer. Pancreas 27(4): 410

Poustka, A.; Kioschis, P.; Laporte, J.; Hu, L.J.; Mandel, J.L.; Dahl, N. 2001: Tyrosine-phosphatase-related protein. Official Gazette of the United States Patent and Trademark Office Patents 1252(1)

Coker, M.; Arikan, C.; Ozgenc, F.; Akman, S.; Goksen, D.; Aydogdu, S.; Darcan, S.; Tokat, Y.; Yagci, R. 2002: Tyrosinemia type 1 A baby with hepatocellular carcinoma. Journal of Inherited Metabolic Disease 25(Suppl 1): 24

Raimann, E.; Jimenez, M.; Cornejo, V.; Valiente, A.; Mabe, P.; Cabello, J.F. 2003: Tyrosinemia type 1, follow-up of 6 cases treated with NTBC in Chile. Journal of Inherited Metabolic Disease 26(Suppl 2): 80

Feng, X.; Teitelbaum, S.L.; Wu, K.K.; Ory, D.S.; Longmore, G.D.; Ross, F.P. 2000: Tyrosines 559 and 807 in the cytoplasmic tail of c-fms, the receptor for M-CSF, are essential for osteoclast differentiation. Journal of Bone and Mineral Research 15(Suppl 1): S511

Lendzian, F.; Galander, M.; Hogbom, M.; Nordlund, P.; Jung, C.; Schuenemann, V.; Barra, A.L.ure 2003: Tyrosyl radicals in iron enzymes Structural information from high-field EPR on frozen solutions and single crystals. Journal of Inorganic Biochemistry 96(1): 64, 15 July

Lawlor, E.J.; Hodgson, J.E. 2000: Tyrosyl tRNA synthetase polynucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)

Ali, M.; Moore, K.; Norman, K.E. 2003: Tyrosylprotein sulfotransferase-1 does not regulate P-selectin-dependent rolling in vivo. FASEB Journal 17(4-5): Abstract 512

Moore, K.L. 2004: Tyrosylprotein sulfotransferases. Official Gazette of the United States Patent and Trademark Office Patents 1280(5)

Moore, K.L. 2001: Tyrosylprotein sulfotransferases and methods of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1244(3)

Moore, K.L. 2000: Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)

Gomez, R.; Gonzalez, M.; Simon, C.; Remohi, J.; Pellicer, A. 2003: Tyroxine hydroxylase downregulation in hyperstimulated ovaries reveals the dopamine agonist Bromocriptine as an effective and specific method to block increased vascular permeability in OHSS. Fertility and Sterility 80(Suppl 3): S43-S44

Chatterjee, M.; Honemann, D.; Herrmann, P.; Bommert, K.; Dorken, B.; Bargou, R.C. 2002: Tyrphostin AG 490 Induces Apoptosis in Multiple Myeloma Cells in the Absence and Presence of Bone Marrow Stromal Cells but Does Not Act Via the STAT3, ERK, or Akt Pathway. Blood 100(11): Abstract No. 5066

Wang, S.; Torestky, J.A.; Kong, D.; Thakar, M.; Zou, T.T.ng T.; Smolinski, K.N.; Gazit, A.; Abraham, J.M.; Meltzer, S.J. 1999: Tyrphostin AG1024, an IGFIR-specific tyrosine kinase inhibitor, diminishes growth and enhances apoptosis in colon cancer cells by blocking IGFIR. Gastroenterology 116(4 Part 2): A526-A527

Beliakoff, J.; Katsanis, E.; Whitesell, L. 2001: Tyrphostin AG1024-mediated inhibition of cellular proliferation and induction of apoptosis in neuroblastoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 853

Natarajan, C.; Sriram, S.; Bright, J.J. 2001: Tyrphostin AG490 inhibits IL-3-induced activation of JAK-STAT pathway in microglia. FASEB Journal 15(5): A1213

Kirken, R.A.; Erwin-Cohen, R.; Behbod, F.; Wang, M.; Stepkowski, S.M.; Kahan, B.D. 2001: Tyrphostin AG490 selectively inhibits activation of the JAK3/STAT5/MAPK pathway and rejection of rat heart allografts. Transplantation Proceedings 33(1-2): 95

Murillo, H.; Huang, H.; Tindall, D.J. 2001: Tyrphostin AG825 triggers P38 MAP kinase-dependent cell death in androgen independent prostate cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 42: 954-955

Jrbano, A.G.; Sausville, E.A.; Foss, F.M. 1999: Tyrphostin AG957 induces apoptosis in leukemia cells via p53 dependent pathway, caspase activation, and BAD dephosphorylation. Proceedings of the American Association for Cancer Research Annual Meeting 40: 485

Awasthi, S.; Singhal, S.S. 2003: Tyrphostin and genistein inhibit ATPase and transport activity of RLIP76 and increase doxorubicin toxicity in lung cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 117

Tang, P.C.; Sun, L.; Nematalla, A.S.; Mcmahon, G. 1999: Tyrphostin like compounds. Official Gazette of the United States Patent and Trademark Office Patents 1225(2)

Banbury, D.; Oakley, J.; Crump, C.; Sessions, R.; Banting, G. 2001: Tyrphostins Inhibitors of membrane traffic pathways?. Biochemical Society Transactions 29(3): A83

Volberg, T.; Tian, B.; Kaufman, P.L.; Geiger, B. 2002: Tyrphostins which interfere with the actin cytoskeleton do not increase outflow facility. Experimental Eye Research 74(3): 411-416

Ruocco, V.; Ruocco, E. 1999: Tzanck smear, an old test for the new millennium: when and how. International Journal of Dermatology 38(11): 830-834

Zareba, W.; Moss, A.J.; Robinson, J.L.; Andrews, M.L. 2004: U waves in long QT1 and long QT2 carriers and non-carriers. Journal of the American College of Cardiology 43(5 Suppl A): 143A-144A

Nishihara, M.; Yokotani, K.; Inoue, S.; Osumi, Y. 1999: U-46619, a thromboxane A2 mimetic, inhibits noradrenaline release from the isolated rat hippocampus. Japanese Journal of Pharmacology 79(Suppl 1): 238P

Szmuszkovicz, J. 1999: U-50,488 and the kappa receptor: a personalized account covering the period 1973 to 1990. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 52: 167-195

Davidson, M.B.; Navar, M.D.; Echeverry, D.; Duran, P. 2010: U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care 33(2): 281-283

Wall, P.M.; Messier, C. 1999: U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation/working memory in CD-1 mice. Society for Neuroscience Abstracts 25(1-2): 66

Bronsaer, R.J.P.; Hofland, M.M.I.; Doevendans, P.A.; Van Der Zee, R. 2000: U-74 inhibits the cytokine induced iNOS expression via elevation of IkappaB and depression of NFkappaB in cultured endothelial cells. Journal of the American College of Cardiology 35(2 Suppl A): 176A

Bronsaer, R.J.P.; Doevendans, P.A.; Van Der Zee, R. 1999: U-74, a 21 aminosteroid-lazaroid selectively inhibits the transcription of iNOS in cultured endo- and myocardial cells. Journal of the American College of Cardiology 33(2 Suppl A): 216A

Reichenberg, K. 2000: U-EPX and severity of asthma. Allergy 55(11): 1090-1091

Chee, Y.L.; Berry, S.; Greaves, M.; Bennett, B. 2004: U-PA expression in normal myeloid differentiation and leukaemia. British Journal of Haematology 125(Suppl 1): 48

Miskin, R.; Masos, T.; Abramovitz, R. 2000: U-PA mRNA is localized in the developing tooth of normal mice and leads to imperfect tooth enamel in alphaMUPA transgenic mice. Fibrinolysis and Proteolysis 14(Suppl 1): 13

Heymans, S.; Padalko, E.; Gao, F.; Van, D.W.rf, F.; Neyts, J.; Carmeliet, P. 2002: U-PA-gene inactivation or TIMP-1-gene transfer impairs cardiac injury caused by viral myocarditis in mice. Circulation 106(19): II309

Gveric, D.; Newcombe, J.; Hanemaaijer, R.; Cuzner, M.L. 2000: U-PA/u-PAR complex in the activation of the plasmin/MMP cascade in MS lesions. FASEB Journal 14(6): A1107

Cunningham, M.J.; Guttmann, G.D.; U Scale Development Team 1999: U-SCALE Project update. FASEB Journal 13(5 Part 2): A707

Rosenfeld, R.; Maya, R.; Smilansky, Z.; Amor, Y.; Rothmann Scherz, C.; Cohen, Y.; Gulko, M.K.; Grosz, A.M.; Bangio, H.; Rosenberg, R.; Schvartzer, L.; Markman, O. 2003: U-c fingerprint Glycoprotein analysis based on a lectin array. Glycobiology 13(11): 845

Vodegel, R.M.; Jonkman, M.F.; Pas, H.H.; De Jong, M.C. 2003: U-serrated immunodeposition pattern differentiates epidermolysis bullosa acquisita from other subepidermal immunobullous diseases. Journal of Investigative Dermatology 121(1): 0079

Larsen, Ebbe Busch 2002: U-shape and/or nozzle u-loop fermentor and method of carrying out a fermentation process. Official Gazette of the United States Patent and Trademark Office Patents 1265(2)

Calabrese, E.J.; Baldwin, L.A. 2001: U-shaped dose-responses in biology, toxicology, and public health. Annual Review of Public Health 22: 15-33

Park, C.R.; Campbell, A.M.; Fleshner, M.; Smith, T.P.; Wilbanks, A.L.; Diamond, D.M. 2001: U-shaped function between corticosterone and spatial memory in stressed rats. FASEB Journal 15(4): A66

Todt, H.; Hilber, K.; Dudley, S.C.; Kudlacek, O.; French, R.J.; Kyle, J.W.; Fozzard, H.A. 2000: U-shaped inactivation in a mutated Na+ channel. Biophysical Journal 78(1 Part 2): 83A

Kelly, K.M.; Zhuang, H.; Nacionales, D.C.; Akaogi, J.; Satoh, M.; Reeves, W.H. 2004: U1RNA stimulates type I interferon inducible gene expression, TLR3 expression, and PKR activation in RAW 2647 cells. FASEB Journal 18(4-5): Abstract 562

Norel, X.; Walch, L.; Brink, C. 2002: U46619 induced contractions Role of prostanoids and nitric oxide in human pulmonary vessels. British Journal of Pharmacology 135(Proceedings Suppl): 282P

Su, X.; Kardos, S.L.; Bielefeldt, K.; Wachtel, R.E.; Gebhart, G.F. 2001: U50,488 modulation of sodium currents in colon sensory neurons. Gastroenterology 120(5 Suppl 1): A 200

Pocock, T.M.; Bates, D.O. 2000: U73122, an inhibitor of phospholipase C inhibits VEGF-mediated increases in hydraulic conductivity. FASEB Journal 14(4): A21

Kohlmann, A.; Reddy, V.A.; Schnittger, S.; Schoch, C.; Haferlach, T.; Mergenthaler, S.; Behre, G.; Hiddemann, W. 2001: U937 cell line transfected with Zinc-inducible PML-RARalpha is a suitable model system for acute promyelocytic leukemia A comparison of gene expression profiles in cell lines and clinical samples. Blood 98(11 Part 2): 160b-161b

Sell, S.M.; Kekes Szabo, T.; Chen, D.; Song, C.; Chen, H.; Baier, L.; Traurig, M.; Hanson, R. 2002: UABSNP58 on human chromosome 20 associated with insulin resistance. American Journal of Human Genetics 71(4 Suppl): 494

Miyashita, Y.taka; Nagahama, Takahiko; Nakamura, Akira; Saito, Ikuo; Saruta, Takao 2002: UAE is significantly associated with hsCRP, PWV, HDL-C and puls pressure. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 243A

Doulami, F.; Robbens, J.; Verstraete, W. 2000: UASB technology for nitrogen removal from wastewaters under OLAND conditions. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 65(4): 169-174

Matisic, D.; Juricic, M.; Bilic, K.; Cvoriscec, D.; Krhen, I.; Marekovic, Z. 2001: UBC II ELISA A new marker of urinary bladder cancer. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S165

Sjodin, A.; Wiklund, B. 2002: UBC II ELISA, an improved immunoassay for monitoring of urinary bladder cancer patients. Tumor Biology 23(Suppl 1): 62

Lal, P.; Corley, N.C. 1999: UBC7-like ubiquitin-conjugating enzyme. Official Gazette of the United States Patent and Trademark Office Patents 1218(4): 3092

Jacquiau, H.R.; Van Waardenburg, R.C.A.M.; Reid, R.J.D.; Bjornsti, M.A.n 2003: UBC9 functions to protect cells from DNA topoisomerase I poisons. Yeast 20(Suppl 1): S113

Shyjan, A.W.; Richardson, J.; Vassiliadis, J. 2002: UBCLP and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1264(4)

Wiklund, K.; Engvall, A.; Goike, H. 2003: UBCTM II RAPID A new qualitative point-of-care test for urinary bladder cancer. Tumor Biology 24(Suppl 1): 79

Nunzi, M.G.; Mugnaini, E. 1999: UBCs axons form a sizeable portion of the mossy fibers in the vestibulocerebellum. Society for Neuroscience Abstracts 25(1-2): 1403

Kitareewan, S.; Sekula, D.; Pitha Rowe, I.; Dmitrovsky, E. 2001: UBE1L A candidate retinoid target in acute promyelocytic leukemia. Proceedings of the American Association for Cancer Research Annual Meeting 42: 389

Webber, H.; Wagstaff, J. 1999: UBE3A mutations in Angelman syndrome Types, hotspots, and origins. American Journal of Human Genetics 65(4): A472

Cuina Sardina, R.; Garcia Feijoo, J.; Castillo, A.; Benitez Del Castillo, J.M.; Lazaro, C.; Arias Puente, A.; Garcia Sanchez, J. 1999: UBM analysis of macrotrabeculectomies Preliminary report. IOVS Investigative Ophthalmology and Visual Science 40(4): S828

D.S.aso, S.; Genitti, G.; D'andrea, D.; Marangolo, L.; Daniele, E.; Aiello, A.; Balestrazzi, E. 1999: UBM study of ciliary body after local Latanoprost in glaucomatous patients. Acta Ophthalmologica Scandinavica 77(Suppl 229): 51

Lally, R.R. 2003: UC Irvine still fire Lessons learned for emergency response and recovery. Abstracts of Papers American Chemical Society 225(1-2): CHAS 3

Rigo, J.M.; Nguyen, L.; Hans, G.; Belachew, S.; Moonen, G.; Matagne, A.; Klitgaard, H. 2004: UCB 34714 effect on inhibitory and excitatory neurotransmission. Epilepsia 45(Suppl 3): 56

Margineanu, D.G.; Schlobohm, I.; Klitgaard, H. 2004: UCB 34714, a new pyrrolidone anticonvulsant, had no effect on voltage-gated potassium currents in cultured mouse hippocampal neurons. Epilepsia 45(Suppl 3): 116

Ellis, J.L.; Libertine, L.; Eckman, J.B.; Wypij, D.M.; Wels, B.F.; Eckert, M.; Cai, X.; Scannell, R.T.; Selig, W.M. 2001: UCB 34743, a novel anti-inflammatory agent posessing both H1 antagonist and 5-lipoxygenase inhibitory activity. Inflammation Research 50(Suppl 3): S184

Hara, M.; Akinaga, S.; Kanda, Y.; Powers, T.S.; Johnson, D.A. 2002: UCF116 derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)

Hara, M.; Soga, S.; Itoh, M.; Shono, K.; Eishima, J.; Mizukami, T. 2000: UCF116, new inhibitors of farnesyltransferase produced by Streptomyces. Journal of Antibiotics 53(7): 720-723

Hara, M.; Soga, S.; Shono, K.; Eishima, J.; Mizukami, T. 2001: UCF76 compounds, new inhibitors of farnesyltransferase produced by Streptomyces. Journal of Antibiotics 54(2): 182-186

Benton, D.C.H.; Dunn, P.M.; Chen, J.Q.; Galanakis, D.; Ganellin, C.R.; Malik Hall, M.; Shah, M.; Haylett, D.G.; Jenkinson, D.H. 1999: UCL 1848 A novel bis-quinolinium cyclophane which blocks apamin-sensitive K+ channels with nanomolar affinity. British Journal of Pharmacology 128(Proceedings Suppl ): 39P

Farrington, L.; Mayerberger, S.; Aguilar, C.; Choe, K.H.ung 2002: UCLA Astrobiology Society Pathfinder group. Astrobiology 2(4): 463

Yip, I.; Aronson, W.; Elashoff, R.; Go, W.L.V.; Dekernion, J.; Heber, D. 1999: UCLA nutrition adjuvant study for treatment of prostate cancer. FASEB Journal 13(4 Part 1): A370

Sugiyama, K.; Shimizu, M.; Akiyama, T.; Yamashita, K.; Tamaoki, T.; Futami, H.; Yamaguchi, K.; Eastman, A.; Akinaga, S. 2000: UCN-01 abrogates cisplatin-induced S and G2 arrest and enhances anti-tumor activity in vivo. Proceedings of the American Association for Cancer Research Annual Meeting 41: 31-32

Mack, P.C.; Gustafsson, M.H.; Jones, A.A.; Gumerlock, P.H.; Goldberg, Z. 2003: UCN-01 as a radiation-sensitizing agent in non-small cell lung carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 44: 139-140

Redkar, A.A.; Daoud, S.S. 1999: UCN-01 dose-dependent protective effect of normal tissues in mice. Proceedings of the American Association for Cancer Research Annual Meeting 40: 11

Kubota, T.; Abe, S.; Furukawa, T.; Otani, Y.; Watanabe, M.; Kitajima, M. 2002: UCN-01 enhances 5-fluorouracil-cytotoxicity through down-regulation of thymidylate synthetase messenger RNA. Proceedings of the American Association for Cancer Research Annual Meeting 43: 66-67

Hsueh, C.T.; Schwartz, G.K. 1999: UCN-01 enhances 5-fluorouracil-induced apoptosis through caspase activation and ubiquitin-proteasome-dependent degradation of E2F-1. Proceedings of the American Association for Cancer Research Annual Meeting 40: 400-401

Tian, H.; Jorgensen, T.J. 2000: UCN-01 enhances radiation-induced apoptosis in cells deficient in p53 and its downstream proteins. Proceedings of the American Association for Cancer Research Annual Meeting 41: 293

Somerville, L.; Cory, J.G. 1999: UCN-01 enhances roscovitine-induced apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells. Proceedings of the American Association for Cancer Research Annual Meeting 40: 11

Bhonde, M.; Magrini, R.; Hanski, M.L.; Riede, E.; Lenz, M.; Notter, M.; Scheruebl, H.; Zeitz, M.; Boland, C.R.; Sausville, E.; Hanski, C. 2002: UCN-01 induces a burst of apoptosis in mismatch repair-deficient but not in the mismatch repair-proficient colon carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 43: 66

Yamauchi, T.; Plunkett, W. 2001: UCN-01 inhibits DNA repair initiated by ultraviolet-C or by the cyclophosphamide prodrug, 4-hydroperoxycyclophosphamide, and induces greater than additive cytotoxicity in normal lymphocytes. Proceedings of the American Association for Cancer Research Annual Meeting 42: 557

Kubota, T.; Abe, S.; Otani, Y.; Watanabe, M.; Kitajima, M. 2001: UCN-01 inhibits in vivo growth of human cancer cells through selective perturbation on G1 phase checkpoint machinery. Proceedings of the American Association for Cancer Research Annual Meeting 42: 801

Kohn, E.A.; Blank, D.H.; Gribble, G.W.; Eastman, A. 2002: UCN-01, ICP-1 and Go6976 are potent inhibitors of the S and G2 DNA damage checkpoint but exhibit many differences with regard other activities. Proceedings of the American Association for Cancer Research Annual Meeting 43: 664-665

Mack, P.C.; Gustafsson, M.H.; Gumerlock, P.H.; Goldberg, Z. 2002: UCN-01-mediated enhancement of radiation cytotoxicity is schedule-dependent in non-small cell lung carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 649

Nishi, M.; Kosaka, M.; Furuta, H.; Tamai, M.; Kawashima, H.; Ogawa, K.; Hanabusa, T.; Sasaki, H.; Nanjo, K. 2002: UCP-2 gene promoter polymorphism affect not obesity but insulin requirement in Japanese type 2 diabetic patients. International Journal of Obesity 26(Suppl 1): S121

Perret, P.; Zhang, C.Y.; Neschen, S.; Lowell, B.B.; Shulman, G.I. 2001: UCP-2 is a negative modulator of insulin secretion in vivo. Diabetes 50(Suppl 2): A10

Sasahara, M.; Nishi, M.; Furuta, H.; Matsumoto, E.; Sasaki, H.; Nanjo, K. 2003: UCP-2 promoter polymorphism affects its expression in beta cells and modulates clinical profiles of Japanese Type 2 diabetic patients. Diabetologia 46(Suppl 2): A133

Nedergaard, J.; Cannon, B. 2002: UCP1 and energy balance. International Journal of Obesity 26(Suppl 1): S216

Kopecky, J. 2002: UCP1 expression in white adipose tissue and lipid metabolism. International Journal of Obesity 26(Suppl 1): S218

Rodriguez, A.M.; Roca, P.; Palou, A. 2001: UCP1, UCP2, UCP3 and beta3-AR expression in male rats Effects of cold in overweight animals. International Journal of Obesity 25(Suppl 2): S39

Fulop, P.; Wands, J.; Baffy, G. 2002: UCP2 affects fasting-induced steatosis and metabolic parameters in lean and obese mice. Hepatology 36(4 Part 2): 413A

Oliver, P.; Pericas, J.; Guitard, R.; Pico, C.; Palou, A. 2000: UCP2 and leptin gene expression in adipose tissue in humans Effects of age and gender. International Journal of Obesity 24(Suppl 1): S52

Cheng, G.; Polito, C.C.; Haines, J.K.; Zhou, X.; Schmidt, M.; Chavin, K.D. 2003: UCP2 expression in mouse hepatocytes is regulated by intracellular ATP and is associated with cell proliferation. Hepatology 38(4 Suppl 1): 560A

Zhang, C.Y.; Lowell, B.B. 2001: UCP2 is a negative regulator of glucose-stimulated insulin secretion. Biochemical Society Transactions 29(5): A99

Nedergaard, J.; Matthias, A.; Ohlson, K.B.E.; Fredriksson, J.M.; Jacobsson, A.; Cannon, B. 2000: UCP2 or UCP3 cannot substitute for UCP1 in NE- or FFA-induced thermogenesis. International Journal of Obesity 24(Suppl 1): S61

Chan, Catherine; De Leo, Domenica; Joseph, Jamie; Mcquaid, Timothy; Saleh, Monique; Xu, Fang; Pennefather, Peter; Salapatek, Annemarie; Wheeler, Michael 2001: UCP2 regulates insulin secretion in beta-cells. Diabetes 50(Suppl 2): A51-A52

Krauss, S.; Zhang, C.Y.; Lowell, B.B. 2001: UCP2, expressed at endogenous levels, mediates mitochondrial proton leak in mammalian cells. Biochemical Society Transactions 29(5): A120

Riechman, S.E.; Balasekaran, G.; Ferrell, R.E. 2004: UCP3 Exon 5 Gene Variation and Resistance Exercise Training Responses in MERET. FASEB Journal 18(4-5): Abstract 851

Iossa, S.; Lionetti, L.; Mollica, M.P.; Crescenzo, R.; Botta, M.; Liverini, G.; Samec, S.; Dulloo, A.G. 2002: UCP3 and basal proton leak in sub-populations of mitochondria isolated from skeletal muscle of fed, fasted and overfed rats. International Journal of Obesity 26(Suppl 2): S59

Harper, M.E.; Dent, R.M.; Bezaire, V.; Antoniou, A.; Gauthier, A.; Monemdjou, S.; McPherson, R. 2001: UCP3 and its putative function: consistencies and controversies. Biochemical Society Transactions 29(Part 6): 768-773

Canas, X.; Nagase, I.; Yubero, P.; Irie, Y.; Fernandez Lopez, J.A.; Kimura, K.; Remesar, X.; Alemany, M.; Saito, M. 2000: UCP3 mRNA induction in Zucker rats in vivo and in HB2 and L6 cells by T3. International Journal of Obesity 24(Suppl 1): S61

Costford, S.R.M.; Doucet, L.S.; Harper, M.E.len 2003: UCP3 overexpression in muscle of mice fed a high fat diet protects against obesity and impaired glucose tolerance. FASEB Journal 17(4-5): Abstract 196

Flandin Blety, P.; Donati, Y.; Arboit, P.; Kuhne, F.; Barrazone, C.; Piguet, P.F.; Muzzin, P. 2003: UCP3 protein and messager are differentially regulated in skeletal muscle of mouse exposed to high exygen concentration. International Journal of Obesity 27(Suppl 1): S48

Hesselink, M.K.C.; Schaart, G.; Slieker, L.J.; Saris, W.H.M.; Schrauwen, P. 2000: UCP3 protein is differentially expressed in human type 1 and type 2 muscle fibres. International Journal of Obesity 24(Suppl 1): S17

Nakai, R.; Ogawa, H.; Asai, A.; Ando, K.; Agatsuma, T.; Matsumiya, S.; Akinaga, S.; Yamashita, Y.; Mizukami, T. 2000: UCS1025A, a novel antibiotic produced by Acremonium sp. Journal of Antibiotics 53(3): 294-296

Niewmierzycka, S.; Mcdonald, W.; Karnezis, A.N.; Tihan, T. 2003: UCSF experience in neuropathology frozen section diagnoses. Modern Pathology 16(1): 292A

Yao, F.; Ferrell, L.; Bass, N.M.; Watson, J.; Ascher, N.; Roberts, J. 2001: UCSF modified staging criteria for liver transplantation in patients with hepatocellular carcinoma Comparison of prognostic power with the Milan criteria and the Pittsburgh modified TNM criteria. Hepatology 34(4 Pt 2): 448A

Sugimoto, K.; Katsuya, T.; Ishikawa, K.; Iwashima, Y.; Yamamoto, K.; Fu, Y.; Matsuo, A.; Motone, M.; Rakugi, H.; Ogihara, T. 2003: UCSNP-43 G/A polymorphism of calpain-10 gene is associated with hypertension and dyslipidemia in Japanese population. American Journal of Hypertension 16(5 Part 2): 82A

Mizukami, T.; Asai, A.; Ando, K.; Kakita, S.; Mihara, A.; Kita, K.; Suzuki, Y.; Ashizawa, T. 1999: UCT1072 compounds. Official Gazette of the United States Patent and Trademark Office Patents 1227(4)

Laub, M.J.; Dederichs, F.; Hermans, M.; Jennissen, H.P. 2001: UCaM-isopeptidase differs from isopeptidase T-like activity in substrate specificity. FASEB Journal 15(4): A24

Mas, N.; Mas, M.R.; Tasci, I.; Sargon, M.; Comert, B.; Isik, A.T.; Ozkomur, E.; Kocar, I.H. 2004: UDCA plus PEG-IFN alpha treatment improves hepatocyte ultrastructure in rat liver fibrosis. Journal of Hepatology 40(Suppl 1): 62

Coward, J.K.; Hartman, M.C.T.; Jiang, S.; Rush, J.S.; Waechter, C.J.; Kowal, P.; Wang, P.G.orge 2003: UDP- GlcNAc and 5-fluoro-GlcNAc beta-octyl glycoside useful tools for glycobiologists. FASEB Journal 17(4-5): Abstract 125

Kawakita, M.; Ishida, N. 2002: UDP-Gal transporter-1 and -2. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 511-517

Katayama, Y.; Frenette, P.S. 2002: UDP-Galactose Ceramide Galactosyltransferase Activity Is Required for Postnatal Development of Lymphoid-Supporting Bone Marrow Stromal Cells. Blood 100(11): Abstract No. 500

Sparks, S.; Lalor, M.; Orvisky, E.; Huizing, M.; Krasnewich, D.; Sun, M.S.; Dalakas, M.; Gahl, W. 2003: UDP-GlcNAc 2-epimerase activity in hereditary inclusion body myopathy. American Journal of Human Genetics 73(5): 448

Kawakita, M.; Ishida, N. 2002: UDP-GlcNAc transporter. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 518-523

Brandenburg, J.; Soars, M.; Burchell, B.; Orzechowski, A.; Swedmark, S.; Bock Hennig, B.; Bock, K.W.; Muenzel, P.A. 2001: UDP-Glucuronosyltransferase UGT1A6 expression in various tissues of phenobarbital- and beta-naphtho-flavone-treated dogs. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R137

Delriccio, V.; Burdett, E.; Vranic, M.; Rodgers, C.D. 2001: UDP-N-acetyl glucosamine accumulation during fat-induced insulin resistance in L6 myotubes. FASEB Journal 15(4): A625

Clausen, H.; Bennett, P. 1999: UDP-N-acetyl-alpha-D-galactosamine Polypeptide N-acetylgalactosaminyltransferase, GalNAc-T3. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2482

Wallis, N.G.; Fedon, J.C.; Palmer, L.M.; Shilling, L.K. 2001: UDP-N-acetylenolpyruvyglucosamine reductase. Official Gazette of the United States Patent and Trademark Office Patents 1246(1)

Wallis, N.G.; Fedon, J.C.; Palmer, L.M.; Shilling, L.K. 2002: UDP-N-acetylenolpyruvylglucosamine reductase. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)

Schwientek, T.; Clausen, H. 2004: UDP-N-acetylglucosamine galactose-beta1,3-N-acetylgalactosamine-alpha-R / beta1,6-N-acetylglucosaminyltransferase, C2GnT3. Official Gazette of the United States Patent and Trademark Office Patents 1286(3)

Beattie, D.T.; Deresiewicz, R.L.; Lowe, A.M.; Nicholas, R.O.; Palmer, L.M.; Pratt, J.M.; Lonetto, M.A.; Hodgson, J.E. 2001: UDP-N-acetylmuramoyl-l-alanineD-glutamate ligase of staphylococcus aureus. Official Gazette of the United States Patent and Trademark Office Patents 1245(1)

Perry, F.A. 2002: UDP-galactose 4-epimerase Catalysis of hydride transfer in the galactosyl-glucosyl. Abstracts of Papers American Chemical Society 224(1-2): BIOL 7

Clausen, H.; Bennett, E.P.ul 2003: UDP-galactose beta-N-acetyl-glucosamine beta-1,4-galactosyl-transferase, beta4Gal-T2. Official Gazette of the United States Patent and Trademark Office Patents 1270(1)

Clausen, H.; Amado, M. 2004: UDP-galactose beta-N-acetyl-glucosamine beta1,3galactosyltransferases, beta3Gal-T5. Official Gazette of the United States Patent and Trademark Office Patents 1287(1)

Hajdinjak, T.; Zagradignik, B.; Kisner, K. 2002: UDP-glucoronyltransferase 2B15 polymorphism D85Y and the risk of prostate cancer. European Urology Suppls 1(1): 34

Spicer, A.P. 2002: UDP-glucose dehydrogenase. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 375-382

Kiy, T.; Elling, L.; Kula, M.R.gina 2000: UDP-glucose pyro phosphorylase enzymes from nonparasitic protozoa. Official Gazette of the United States Patent and Trademark Office Patents 1240(1)

Hong, Z.; Zhang, Z.; Verma, D.S. 2001: UDP-glucose transferase is part of the callose synthase complex at the forming cell plate. Plant Biology (Rockville) : 118

Yamane, S.Y.; Fujino, T.; Shimoda, K.; Ohta, S.; Hirata, T. 2001: UDP-glucosyltransferase from the cultured cells of Nicotianatabacum. Journal of Molecular Catalysis B Enzymatic 14(1-3): 49, 12 June

Vogel, A.; Barut, A.; Ehmer, U.; Kneip, S.; Goeke, M.; Tukey, R.H.; Manns, M.P.; Strassburg, C.P. 2001: UDP-glucuronosyltransferase UGT1A7 gene polymorphisms discriminate between primary sclerosing cholangitis associated ulcerative colitis and ulcerative colitis. Hepatology 34(4 Pt 2): 241A

Zhang, P.; Turncliff, R.Z.; Johnson, B.M.; Tian, X.; Brouwer, K.L.R. 2003: UDP-glucuronosyltransferase activity in sandwich-cultured rat hepatocytes. Drug Metabolism Reviews 35(Suppl 2): 56

Proudlock, R.J.; Cecchi, C.A.; Adams, K. 2000: UDS in mouse liver - Assay development. Environmental and Molecular Mutagenesis 35(Suppl 31): 49

Dire, C.; Shi, G.; Kahrilas, P.J. 1999: UES pressure measured with a microsleeve Going, going,. Gastroenterology 116(4 Part 2): A987

Novelli, G.; Amati, F.; Dallapiccola, B. 1999: UFD1L and CDC45L: a role in DiGeorge syndrome and related phenotypes?. Trends in Genetics: Tig 15(7): 251-254

Gemma, A.; Ichinose, Y.; Nakai, Y.; Semba, H.; Shibuya, M.; Kudoh, S. 2001: UFT plus cisplatin with concurrent radiotherapy for locally advanced non small-cell lung cancer A multiinstitutional phase II trial Cis-UFT-RT Study Group. European Journal of Cancer 37(Suppl 6): S56

Minsky, B.D. 2001: UFT plus oral leucovorin calcium and radiation in combined modality therapy A comprehensive review. International Journal of Cancer 96(1): 1-10, 2 February

Van Cutsem, Eric 2003: UFT/LV A novel concept in the chemotherapy of metastatic colorectal cancer. Anti-Cancer Drugs 14(Suppl 2): S3-S4

Zelek, L. 2003: UFT/LV Patient preference for oral therapy. Anti-Cancer Drugs 14(Suppl 2): S9

Bokemeyer, C. 2003: UFT/LV in heavily pretreated patients. Anti-Cancer Drugs 14(Suppl 2): S8

Earnest, D.L.; Lefkowtiz, M.L.; D'elia, T.; Dainous, F.; Sue, S.O.; Ligozio, G.; Vandeplassche, G. 2002: UGI dysmotility symptoms in patients with NERD correlate with heartburn severity Support for a functional disorder. Gastroenterology 122(4 Suppl 1): A579-A580

Heeney, M.M.; Howard, T.A.; Ware, R.E. 2002: UGT1A promoter mutations affect the reduction in serum bilirubin in children with sickle cell anemia receiving hydroxyurea therapy. Pediatric Research 51(4 Part 2): 245A

Carpenter, S.L.; Eggleston, B.; Howard, T.A.; Lail, A.; Lieff, S.; Ware, R.E. 2003: UGT1A promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Blood 102(11): 760a

Ware, R.E.; Eggleston, B.; Carpenter, S.L.; Lail, A.; Lieff, S.; Howard, T.A. 2003: UGT1A promoter polymorphisms in sickle cell anemia Analysis of variant 5 and 8 alleles and identification of an age effect. Blood 102(11): 764a

Smith, C.M.; Lecluyse, E.L. 2003: UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 cells. Drug Metabolism Reviews 35(Suppl 2): 122

Marcuello, E.; Menoyo, A.; Del Rio, E.; Gomez Pardo, M.; Balcells, M.; Baiget, M. 2003: UGT1A1 polymorphisms correlate with adverse side effects and clinical response in metastatic colorectal cancer patients treated with Irinotecan. EJC Suppls 1(5): S180

Zhai, S.; Sausville, E.A.; Senderowicz, A.M.; Ando, Y.; Headlee, D.; Messmann, R.A.; Arbuck, S.; Murgo, A.J.; Melillo, G.; Fuse, E.; Figg, W.D. 2003: UGT1A1 promoter polymorphism did not affect flavopiridol pharmacokinetics and diarrhea in patients with refractory neoplasms. Proceedings of the American Association for Cancer Research Annual Meeting 44: 925

Zheng, Z.; Elahi, A.; Muffly, B.J.; Richie, J.; Lazarus, P. 2002: UGT1A10 polymorphisms Elucidation and prevalence in multiple racial groups. Proceedings of the American Association for Cancer Research Annual Meeting 43: 402

Zalatoris, J.J.; Raftogianis, R.B. 2001: UGT1A6 genetic polymorphisms Identification and genotype/phenotype analysis from human liver tissues. Clinical Pharmacology and Therapeutics 69(2): P77

Bendaly, J.; Dossett, N.; Elahi, A.; Mericle, L.; Richie, J.P.J.; Lazarus, P. 2003: UGT1A9 and UGT2B7 polymorphisms Identification and prevalence in multiple racial groups. Proceedings of the American Association for Cancer Research Annual Meeting 44: 509-510

Court, M.H.; Hao, Q.; Bekaii Saab, T.; Krishnaswamy, S. 2003: UGT2B15 genotype and gender significantly influence oxazepam glucuronidation by human liver microsomes. Drug Metabolism Reviews 35(Suppl 2): 55

Sparks, R.; Ulrich, C.M.; Bigler, J.; Aiello, E.J.; Tworoger, S.S.; Mctiernan, A. 2002: UGT2B4, UGT2B7, and UGT2B15 polymorphisms, breast cancer stage at diagnosis and tumor characteristics. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1017-1018

Duguay, Y.; Guillemette, C. 2003: UGT2B7 Novel genomic variants in the promoter and functional consequences. FASEB Journal 17(4-5): Abstract 155

Payk, T.R. 2004: UH Peters Pros and cons of Chapter V of ICD-10, Fortschr Neurol Psychiat 2003; 71 115 - 117. Fortschritte der Neurologie Psychiatrie 72(8): 487

Schaffner, S. 2001: UHMW polyethylene for implants. Official Gazette of the United States Patent and Trademark Office Patents 1249(3)

Mutti, F.; Giuffredi, F. 2000: UHT sterilization process for milk-based products. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)

Burger, M.M. 2002: UICC study group on basic and clinical cancer research: mechanisms of metastasis. Journal of Cellular Biochemistry 87(3): 253-257

Utsunomiya, J.; Arai, M.; Hayashi, T.; Miki, T.; Muto, T.; Tamura, K.; Iwama, T.; Nozumi, S.; Shirahama, S.; Yamaguchi, N.; Tominaga, S. 2002: UICC familial cancer and prevention project in Japan Constructing infrastructure for translational research/interventional prevention trial. International Journal of Cancer Suppl (13): 190

Burger, M.M. 2000: UICC Study Group on Basic and Clinical Cancer Research: angiogenesis revisited. International Journal of Cancer 88(5): 835-837

Zisman, A.; Pantuck, A.J.; Chao, D.H.; Dorey, F.; Said, J.W.; Dekernion, J.B.; Figlin, R.A.; Belldegrun, A.S. 2002: UISS-based clinical algorithm to predict outcome of patients with localized and advanced renal cell carcinoma. Journal of Urology 167(4 Suppl): 169

Wass, J.A.H.; Carson, M.N.; Bates, P.; Bevan, J.S.; Scanlon, M.; Stewart, P.M.; Walker, B.; Besser, G.M.; Clayton, R.N.; Jenkins, P.J. 2000: UK Acromegaly Database Results of surgery. Journal of Endocrinology 164(Suppl ): P54

Hamblin, T.J. 2002: UK CLL Forum, London, 25th October 2001. Leukemia Research 26(6): 607-609

Phillips, C.P.; Thacker, C.; Sandher, S.; Syndercombe Court, D. 2000: UK Caucasian databases for six Y chromosome STRs. Sensabaugh, George F Author, Lincoln, Patrick Journal Author, Olaisen, Bjornar Author International Congress Series Progress in forensic genetics 8 290-292

Short, C.; Milburn, A. 2002: UK Government and WHO. Lancet 360(9343): 1422

Monson, J.P. 1999: UK KIMS database. Journal of Endocrinology 163(Suppl ): SP11

Middle, J.G.; Mackenzie, F.; Bullock, D.G. 1999: UK NEQAS for glycated haemoglobins target values and method means compared with those obtained by a certified DCCT reference method. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S292

Wass, J.A.H.; Clayton, R.N. 1999: UK acromegaly database. Journal of Endocrinology 163(Suppl ): SP10

Ross, R.J.M. 2000: UK audit of adult congenital adrenal hyperplasia care. Journal of Endocrinology 164(Suppl ): S38

Wonderling, D.; Hopwood, P.; Cull, A.; Douglas, F.; Watson, M.; Burn, J.; Mcpherson, K. 2000: UK cancer genetics services The response to a new need. Journal of Medical Genetics 37(Suppl 1): S34

Arvinen-Barrow,M.; Penny,G.; Hemmings,B.; Corr,S. 2010: UK chartered physiotherapists personal experiences in using psychological interventions with injured athletes an Interpretative Phenomenological Analysis. Psychology Of Sport And Exercise: 1, 58-66

Bennett, C.C. 2001: UK collaborative ECMO Trial Follow-up at four years of age. Pediatric Research 49(2): 263

Edwards, C.; Nicholls, D.; Van Zyl, S.; Viner, R.; Wardle, J. 2003: UK evaluation of a family-based group intervention for childhood obesity Pilot results. International Journal of Obesity 27(Suppl 1): S105

Atkin, W.S.; Edwards, R.; Wardle, J.; Northover, J.M.; Cuzick, J. 2000: UK flexible sigmoidoscopy screening trial Compliance, yield and adverse effects. Gastroenterology 118(4 Suppl 2 Pt 1): A187

Mitchell, P. 1999: UK government restricts the use of sildenafil. Lancet (North American Edition) 353(9165): 1687

Teare, E.L.; Cookson, B.; French, G.L.; Jenner, E.A.; Scott, G.; Pallett, A.; Gould, D.; Schweiger, M.; Wilson, J.; Stone, S. 1999: UK handwashing initiative. Journal of Hospital Infection 43(1): 1-3

Nuttall, M.; Brown, C.; Van Der Meulen, J.; Emberton, M. 2004: UK hospital and surgeon volumes for urological cancer care and surgeons views on minimum volume thresholds. European Urology Suppls 3(2): 152

Wise, J. 1999: UK introduces new meningitis C vaccine. BMJ 319(7205): 278

Anon 1999: UK investors in merge talks. Nature Biotechnology 17(1): 8

Hope, B. 1999: UK lags behind in fight against heart disease. BMJ 318(7193): 1229

Macdougall, I.C. 1999: UK multicenter randomized controlled study of IV vs oral iron supplementation in dialysis patients receiving epoetin. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 291A

Macdougall, I.C.; Kwan, J.; Temple, R.M.rk 2001: UK multicentre randomised controlled study of epoetin alfa in early renal insufficiency A 12-month interim analysis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 395A

Passmore, S.J.; Chessells, J.M.; Hann, I.M.; Brownbill, P.A.; Stiller, C.A. 2000: UK paediatric myelodysplasia register 1990-1999 Problems and pitfalls. Leukemia 14(5): 968

Johnson, L.; Bliss, J.; Ellis, P.; Barrett Lee, P.; Johnston, S.; Yarnold, J. 2003: UK patients are willing to donate biological material for sub-studies in clinical trials. EJC Suppls 1(5): S127

Boulton, F.E.; Caffrey, E.A. 2002: UK policies to minimize transmission of Trypanosoma cruzi by blood transfusion and organ transplantation. Vox Sanguinis 83(Suppl 2): 31-32

Fletcher, A.P. 1999: UK primary care databases lead the way. Adverse Drug Reactions and Toxicological Reviews 18(2): 57-60

Davies, M.J. 1999: UK research programme on the characterization of vehicle particulate emissions. Maynard, R L Author, Howard, C V Author Particulate matter: Properties and effects upon health 145-157

Collins, P.W.; Baglin, T.P.; Hill, F.G.H.; Keeling, D.M.; Hay, C.R.M. 2003: UK surveillance of acquired haemophilia A May 2001-April 2002. British Journal of Haematology 121(Suppl 1): 92

Tani, K.; Usuki, Y.; Fujita, K.-I.; Taniguchi, M. 2003: UK-2A, B, C, and D, novel antifungal antibiotics from Streptomyces sp. 517-02. VIII. Reactive oxygen species generated by C9-UK-2A, a derivative of UK-2A, in Rhodotorula mucilaginosa IFO 0001. Journal of Antibiotics 56(3): 314-317

Pinder, S.E.; Ellis, I.O.; Duggan, C.; Cuzick, J.; Houghton, J.; George, D. 2000: UKCCCR DCIS Trial The histopathology review. Journal of Pathology 192(Suppl): 5A

Mussivand, T. 2000: Mechanical circulatory devices for the treatment of heart failure. Journal of Cardiac Surgery 14(3): 218-228

Carmichael, J. 2001: UKCCCR trial of epirubicin and cylophosphamide vs epirubicin and taxol in the first line treatment of women with metastatic breast cancer. British Journal of Cancer 85(Suppl 1): 2

Cuzick, J.; George, W.D.; Houghton, J. 2001: UKCCCR trial of tamoxifen and/or radiotherapy for DCIS. British Journal of Cancer 85(Suppl 1): 2

Felix, C.; Roberts, P.; Burchill, S.A.; Lewis, I.J. 2000: UKCSSG study of karyotype data for children, adolescents and adults diagnosed with tumours of the Ewings sarcoma family. Journal of Medical Genetics 37(Suppl 1): S40

Vaughan, N.J.A.; Roxburgh, M.; New, J. 2000: UKDIABS A UK diabetes population analysis. Diabetologia 43(Suppl 1): A111

Protopsaltis, J.; Kostadinopulos, P.; Kyriazis, I.A.; Bonovas, S.; Kamaratos, A.; Iraklianou, S.; Melidonis, A. 2003: UKPDS model vs Framingham model in the prediction of ten year risk of coronary heart disease in individuals with Type 2 diabetes. Diabetes and Metabolism 29(Hors serie 2): 4S36

Shanmugarajah, P.; Low, A.; Robinson, R.; Roddick, J.; Tesfaye, S. 2003: UKPDS targets are not being achieved in Primary and Secondary Care in the United Kingdom. Diabetes 52(Suppl 1): A504

Coen, D.M.; He, Z. 1999: UL97 fusion proteins and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1223(4)

Cosman, D.J.; Mullberg, J.; Fanslow, W.C.IIi; Kubin, M.; Armitage, R.J.ffrey 2002: ULBP DNA and polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1263(1)

Kubin, M.; Armitage, R.; Cassiano, L.; Chalupny, J.; Chin, W.; Cosman, D.; Fanslow, W.; Mullberg, J.; Rousseau, A.M.; Ulrich, D. 2000: ULBP-1,-2,-3, novel MHC class I-related molecules which bind to human cytomegalovirus glycoprotein UL-16, activate NK cells. Immunology Letters 73(2-3): 197

Sutherland, C.L.; Chalupny, N.J.; Lynch, D.; Miller, R.; Cosman, D. 2002: ULBPs, human MHC class I related NKG2D ligands, activate multiple signaling pathways and stimulate NK killing of tumour targets. Journal of Interferon and Cytokine Research 22(Suppl 1): S-154-S-155

Sutherland, C.L.; Chalupny, J.; Schooley, K.; Vandenbos, T.; Kubin, M.; Cosman, D. 2001: ULBPs, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. Journal of Leukocyte Biology Suppl: 62-63

Narvaez, D.; Lillich, J.; Hoffman, J.; Freeman, L. 2004: Ulcerogenic Nsaids Depolarize Iec-6 Cells, Inhibit cell Migration without Consistent Alteration to Kv15 Expression or Depletion of Polyamines. FASEB Journal 18(4-5): Abstract 838

Perez Perez, J.M.; Ponce, M.R.; Micol, J.L. 2001: ULTRACURVATA1, a SHAGGY-like Arabidopsis gene required for cell elongation. International Journal of Developmental Biology 45(Supp 1): S51-S52

Michel, U.; Kallmann, B.; Rieckmann, P.; Isbrandt, D. 2002: UM 9 h and UM 9 p, human and porcine noncoding transcripts with preferential expression in the cerebellum. RNA (New York) 8(12): 1538-1547

Beroud, C.; Ben Yaou, R.; Helbling Leclerc, A.; Llense, S.; Kaplan, J.C.; Leturcq, F.; Recan, D.; Bonne, G. 2002: UMD-STA and UMD-LMNA Locus Specific Data Bases for emerinopathy and laminopathy. European Journal of Human Genetics 10(Suppl 1): 200

Quiles, J.; Souto, M.; Tahoces, P.G.; Vidal, J.J. 2003: UML modelling for digital mammography softcopy work pattern Application to formal user interface design and evaluation. Lemke, Heinz U , Reprint Author, Vannier, Michael W, Inamura, Kiyonari, Farman, Allan G, Doi, Kunio, Reiber, John H C Computer assisted radiology and surgery: 1331

Podlaska, A.; Mieczkowski, P.; Skoneczna, A.; Sledziewska Gojska, E. 2000: UMP1 is induced by DNA damage and required for the resistance of Saccharomyces cerevisiae to UV light. Biochemical Society Transactions 28(5): A167

Christen, K. 2004: UN sets treatment standard for ballast water. Environmental Science and Technology 38(9): 153a-154a

Waterhouse, J.; Weinert, D.; Nevill, A. 2001: UN-masking temperature data An overview. Chronobiology International 18(6): 1210-1211

Ramsay, S. 1999: UNAIDS to publish HIV-vaccine-trial ethics guidance. Lancet 354(9182): 923

Jorgensen, E.; Richmond, J.; Weimer, R.; Koushika, S.; Nonet, M. 2001: UNC-13 and Rim prime synaptic vesicles by opening syntaxin. Biology of the Cell 93(3-4): 137

Price, M.G.; Barral, J.M.; Hutagalung, A.H.; Brinker, A.; Hartl, F.U.; Epstein, H.F. 2001: UNC-45 is a myosin- and Hsp90-binding chaperone with genetically distinct mammalian isoforms required for cytoskeletal or sarcomeric functions. Molecular Biology of the Cell 12(Suppl): 159a-160a

Fridolfsson, H.N.; Ly, N.; Meyerzon, M.; Starr, D.A. 2010: UNC-83 coordinates kinesin-1 and dynein activities at the nuclear envelope during nuclear migration. Developmental Biology 338(2): 237-250

Ulyanov, N.B.; Du, Z.; Yu, J.; Comolli, L.R.; Gmeiner, W.H.; James, T.L. 2003: UNCG or YNMG?. Journal of Biomolecular Structure and Dynamics 20(6): 943

Calcagno, A.T.; Wallace, P. 2003: UNEP Dams and Development Project contribution to WLV call for action. IAGLR Conference Program and Abstracts 46: 34-35

Roots, F. 2000: UNESCO MAB Northern Sciences Network United Nations science across borders. Arctic Science Conference Abstracts 51: 55-56

Bhasin, N. 2004: UNF chemistry on a single protein during forced unfolding by AFM. Biophysical Journal 86(1): 88a

Kauffman, H.M.; McBride, M.A.; Delmonico, F.L. 2001: UNOS Transplant Tumor Registry: donors with a history of cancer. Transplantation Proceedings 33(1-2): 1844-1845

Ichida, T.; Iwatsuki, S.; Kakumu, S. 2001: UNOS-selection criteria and order of priority for the candidate of liver transplantation. Nihon Shokakibyo Gakkai Zasshi 98(1): 1-7

Markovits, J.; Huet, S.; Dormoy, V.; Montaudon, D.; Jacquemin Sablon, A.; Jacquemin Sablon, H. 2003: UNR, a cytoplasmic RNA-binding protein modulates ES cells survival following DNA damage. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1330-1331

Hasegawa, M.; Sato, S.; Takehara, K. 2004: UP-regulated expression of fractalkine and CX3CR1 in patients with systemic sclerosis. Journal of Dermatological Science 34(2): 137

Oliveira, A.C.; Parise, E.R.; Lanzoni, V.; Martins, J.R.; Nader, H.; Ferraz, M.L.; Reber, M. 2002: UP-regulated microssomal activity measured by the 13C-methacetine breath test is associated with increased fibrogenesis in chronic hepatitis C. Hepatology 36(4 Part 2): 565A

Waldron, K.G.; Siddique, K.; Yanamandra, N.; Dinh, D.H.; Olivero, W.C.; Gujrati, M.; Rao, J.S. 2003: UPA and MMP-2 are upregulated during the progression of tumor and compression of spinal cord in a mouse model of vertebral body melanoma metastasis. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1175

Offersen, B.; Pfeiffer, P.; Andreasen, P.; Overgaard, J. 2003: UPA and PAI-1 are associated with angiogenesis but not prognosis in non-small cell lung carcinoma. EJC Suppls 1(5): S234

Duffy, M.J. 2003: UPA and PAI-1 as prognostic markers in breast cancer Validation using level 1 evidence studies. Tumor Biology 24(Suppl 1): 19

Harbeck, N.; Jaenicke, F.; Schmitt, M.; Thomssen, C. 2004: UPA and PAI-1 in primary breast cancer From bench to bedside. EJC Suppls 2(3): 26-27

Jarosz, D.E.; Morris, L.D.; Tighe, W.J.; Walsh, S.B.; Trivedi, D.R.; Carney, W.P.; Hamer, P.J. 2002: UPA and uPAPAI-1 complexes in serum and plasma. Tumor Biology 23(Suppl 1): 54

Nekarda, H.; Etter, M.; Boettcher, K.; Mueller, J.D.; Gerein, P.; Schmitt, M.; Siewert, J.R. 2000: UPA expression is an important component of an accurate prognostic model for completely resected gastric carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 41: 638

Pakneshan, P.; Xing, R.H.; Rabbani, S.A. 2002: UPA promoter methylation status as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo Potential diagnostic and therapeutic implications. Proceedings of the American Association for Cancer Research Annual Meeting 43: 137

Wittliff, J.L.; Tecimer, C.; Doering, D.L. 2000: UPA, uPAR and PAI-1 expression in the management of endometrial and ovarian cancer. Proceedings of the American Association for Cancer Research Annual Meeting 41: 730

Wang, Z.; Kurpakus Wheater, M. 2001: UPA, uPAR and uPAI-1 levels in hypoxic human corneal epithelial cells. IOVS Investigative Ophthalmology and Visual Science 42(4): S588

Guthaus, E.; Buergle, M.; Schmiedeberg, N.; Hocke, S.; Magdolen, V.; Kessler, H.; Schmitt, M. 2002: UPA-silica-particles as a new tool to assess synthetic peptides to interfere with uPA/uPA-receptor interaction. Anticancer Research 22(6C): 4322-4323

Legrand, C.; Polette, M.; Tournier, J.M.; De Bentzmann, S.; Birembaut, P. 2000: UPA/plasmin system implication in the bronchial epithelial cell migration process. Clinical and Experimental Metastasis 17(9): 769

Besch, R.; Schuh, T.; Berking, C.; Kammerbauer, C.; Degitz, K. 2004: UPAR inhibition in melanoma cells by small interfering RNAs. Journal of Investigative Dermatology 123(2)

Blasi, F.; Fazioli, F.; Resnati, M.; Sidenius, N. 2002: UPAR mimicking peptide. Official Gazette of the United States Patent and Trademark Office Patents 1263(2)

Papenhausen, P.R.; Tepperberg, J.H.; Mowrey, P.N.; Gadi, I.K.; Shah, H.O.; Sherman, J.; Pulijaal, V.; Nitowsky, H.; Sachs, G.; Lin, J.H. 1999: UPD risk assessment Three cytogenetic subgroups. American Journal of Human Genetics 65(4): A353

Trabanelli, C.; Gualandi, F.; Ravani, A.; Sensi, A.; Falciano, F.; Villa, N.; Colombo, D.; Cavani, S.; Grasso, M.; Cecconi, M.; Ferlini, A.; Dalpri, L.; Dagna Bricarelli, F.; Calzolari, E.; Baroncini, A. 2000: UPD risk prenatally identified Robertsonian translocations A collaborative study. European Journal of Human Genetics 8(Suppl 1): 88

Crosti, F.; Miozzo, M.M.; Villa, V.N.; Colombo, C.D.; Sala, S.E.; Martinoli, M.E.; Fuhrman Conti, F.C.A.M.; Nocera, N.G.; Dalpri, D.L. 2000: UPD test in prenatal diagnosis Its use in mosaicisms, structural rearrangements and supernumerary markers. European Journal of Human Genetics 8(Suppl 1): 117

Tinzl, M.; Djavan, B.; Marberger, M. 2003: UPM3 test A new molecular assay detecting prostate cancer in urine samples A new future perspective. European Urology Suppls 2(1): 37

Takeda, Masahiko; Et Al 2003: UPPP Our method. Jibi Inkoka Tokeibu Geka 75(9): 611-615

Schmidt, H.S.; Berendts, B.P.; Hinkle, R.M. 2000: UPPP/LAUP Indicators for treatment success or failure. Journal of Sleep Research 9(Suppl 1): 171

Oonuma, M.; Sunamura, M.; Motoi, F.; Hamada, H.; Fukuyama, S.; Shimamura, H.; Yamauchi, J.; Shibuya, K.; Takeda, K.; Matsuno, S. 2000: UPRT gene therapy using selectively replication competent mutant adenovirus enhances 5-FU anti-tumor effect on pancreatic cancer. Pancreas 21(4): 467

Huang, J.; Jiang, X.; Mcdevitt, D. 2003: Ups. Official Gazette of the United States Patent and Trademark Office Patents 1268(4)

Jason, L.J.M.; Denby, K.J. 2001: UPS1 and UPS2 Arabidopsis thaliana mutants defective in the induction of defence responses following infection by virulent Pseudomonas syringae. South African Journal of Science 97(1-2): vii, January-February

Baba, K.; Aga, Y.; Nakanishi, T.; Motoyama, T.; Ueno, H. 2001: UR-3216: a manageable oral GPIIb/IIIa antagonist. Cardiovascular Drug Reviews 19(1): 25-40

Aga, Y.; Baba, K.; Tam, S.; Nakanishi, T.; Yoneda, K.; Kita, J.-I.; Ueno, H. 2004: UR-3216: a new generation oral platelet GPIIb/IIIa antagonist. Current Pharmaceutical Design 10(14): 1597-1601

Gomez Casajus, L.A.; Cavalcanti, F.L.; Alfon, J.; Merlos, M.; Garcia Rafanell, J. 2001: UR-8880, a new imidazole derivative as potent, selective and orally active COX-2 inhibitor. Inflammation Research 50(Suppl 3): S179

Liu, Y.; Monticone, M.; Tonachini, L.; Mastrogiacomo, M.; Marigo, V.; Quarto, R.; Cancedda, R.; Castagnola, P. 2003: URB gene expression is regulated during mouse embryonic development and down-regulated after osteoblastic differentiation in human BMSC. Tissue Engineering 9(4): 783

Markwell, J.; Brooks, D.W. 2001: URL extinction and its potential impact on science education. Plant Biology (Rockville) : 27

An, G.; Meka, C.S.R.; Ng, A.Y.; Bright, S.; Wang, S.; Vessella, R.L.; Veltri, R.W. 2000: UROC41 A novel gene over expressed in prostate cancer. Proceedings of the American Association for Cancer Research Annual Meeting 41: 41

Harrison, N.W. 2002: UROLINK: a model for working together in a changing world. Bju International 89(Suppl 1): 1-5

Evans, C.M. 2002: UROLINK in sub-Saharan Africa. Bju International 89(Suppl 1): 6-10

Perazzo, G.; Zeller, F.L. 2000: UROSPEC use for diagnosing patients with Benign Prostatic Hyperplasia. Journal of Endourology 14(Suppl 1): A78

Wolfe, R.A.; Held, P.J.; Hulbert Shearon, T.E.; Ashby, V.B.; Port, F.K. 2002: URR 75% is associated with lower mortality among females but not among males. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 20A

Goldwasser, P. 2000: URR, weight, and mortality. Kidney International 57(3): 1206

Yang, E.; Obayashi, S.; Houang, R.; Kerver, J.; Song, W.O. 2004: US Adult Dietary Patterns and Overweight/Obesity. FASEB Journal 18(4-5): Abstract 107

Frykman, P.N.; Harman, E.A.; Pandorf, C.E.; Lafiandra, M.E.; Smith, T.J.; Mello, R.P.; Patton, J.F.; Bensel, C.K.; Obusek, J.P. 2000: US Army boots vs commercial and prototype boots Subjective ratings and foot injuries. Medicine and Science in Sports and Exercise 32(5 Suppl): S109

Calamaio, R.A. 1999: US Burea of Land Management National Training Center Distance Learning Overview. McCabe, R E , Loos, S E Transactions of the North American Wildlife and Natural Resources Conference 328-335

Wehrwein, P. 1999: US CDC makes new vaccine recommendations. Lancet (North American Edition) 353(9151): 478

Paster, M.D. 2002: US Department of Energy Office of Industrial Technologies agriculture biobased products program and other DOE and federal agencies relevant programs. Abstracts of Papers American Chemical Society 223(1-2): PMSE 81

Brooks, A.L. 2002: US Department of Energys Low Dose Radiation Research Program Potential impact on human health risk. AAAS Annual Meeting and Science Innovation Exposition 168: A36, 14-19 February

Spear, B.; Anderson, J.; Mckown, K. 2003: US East Coast Atlantic sturgeon population An overview of management. American Fisheries Society Annual Meeting 133: 227

Telliard, W.; Gomez Taylor, M.; Riddick, L.; Schofield, J. 2000: US Environmental Protection Agency Office of Waters analytical methods, sampling methods, and guidance documents for the determination of trace metals. Abstracts of Papers American Chemical Society 219(1-2): ENVR 220

Ault, A. 1999: US FDA again stops urokinase sales. Lancet (North American Edition) 354(9175): 310

Ault, A. 1999: US FDA may change policy on antimicrobial residues. Lancet (North American Edition) 354(9185): 1190

Pilaro, A.M. 2001: US FDA regulatory expectations for preclinical demonstration of safety of genetic anticancer agents. Cancer Gene Therapy 8(9): 686-687

Mcdonald, M.B.; Frantz, J.M.; Price, F.W.Jr 1999: US LASIK results on myopia and hyperopia with astigmatism with the Autonomous Technologies LADARVision excimer laser system. IOVS Investigative Ophthalmology and Visual Science 40(4): S893

Connett, P. 2003: US National Research Council Subcommittee on Fluoride in Drinking Water. Fluoride 36(4): 280-289

Cravens, J.W. 2001: US Pork products in the international marketplace. Journal of Dairy Science 84(Suppl 1): 14

Woloshin, S.; Schwartz, L.M. 1999: US Postal Service and cancer screening Stamp of approval?. JGIM 14(Suppl 2): 164

Centers For Disease Control (Usa) 2001: US Public Health Service Guideline on infectious disease issues in xenotransplantation. Morbidity and Mortality Weekly Report 50(rr-15): I-Iv, 1-46, Ust 24

Mofenson, L.M. 2002: U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports 51(RR-18): 1-38; quiz CE1-4

Centers For Disease Control And Prevention 2002: US Public Health Service and Infectious Diseases Society of America Prevention of Opportunistic Infections Working Group. Morbidity and Mortality Weekly Report 51(rr-8): 1-52, E 14

Gordon Larsen, P.; Adair, L.S.; Popkin, B.M. 2000: US adolescent physical activity and inactivity patterns are linked with overweight The National Longitudinal Study of Adolescent Health. FASEB Journal 14(4): A260

Sun, C.; Guillory, V.J.; Dew, P.C.; Boyajian, L.A.; Belfer, M. 2001: US adults using the emergency room as their regular place of health care Health status and socio-demographic characteristics. American Journal of Epidemiology 153(11 Suppl): S228

Thacker, P.D. 2004: US and Mexico tackle border pollution. Environmental Science and Technology 38(17): 326a, Ember 1

Menon, V.; Col, J.; Sleeper, L.A.; Menegus, M.; Buller, C.E.; French, J.; Porway, M.; White, H.D.; Webb, J.G.; Boland, J.; Aylward, P.; Hochman, J.S. 2001: US and non US outcomes are similar for patients with cardiogenic shock A report from the SHOCK Trial. Journal of the American College of Cardiology 37(2 Suppl A): 358A

Lauenstein, G.G. 2001: US coastal and estuarine surficial sediment trace element and organic contaminant changes. Abstracts of Papers American Chemical Society 221(1-2): ENVR 72

Gottlieb, S. 1999: US considers ban on British blood. BMJ 318(7198): 1574

Lombardi, V.P.; Troxel, R.K. 2003: US deaths injuries associated with weight training. Medicine and Science in Sports and Exercise 35(5 Suppl): S203

Gottlieb 1999: US effort to cut caesarean section rate may be harmful. BMJ 318(7177): 147B

Mcmanus, R. 2001: US efforts to protect domestic and international coral reefs. AAAS Annual Meeting and Science Innovation Exposition 167: A49, February 15-20

Camargo, C.A.Jr; Roberts, J.; Clark, S. 2001: US emergency department visits for COPD exacerbations between 1992-1998. American Journal of Epidemiology 153(11 Suppl): S80

Stramer, S.L.; Waldman, K.J.; Davis, J.T.; Brodsky, J.P.; Dodd, R.Y. 2000: US experience with nucleic acid testing for HIV-1 and HCV. Vox Sanguinis 78(Suppl 1): O070

Frankel, D.H. 1999: US experts take the threat of bioterrorism seriously. Lancet (North American Edition) 353(9154): 734

Coleman-Jensen,A.J. 2010: US food insecurity status toward a refined definition. Social Indicators Research: 2, 215-230

Thacker, P.D. 2004: U.S. forest fire policies get flamed. Environmental Science and Technology 38(17): 324a-325a

Mccammon, S. 2003: US government regulation of transgenic pharmaceutical-containing plants. Abstracts of Papers American Chemical Society 225(1-2): BTEC 16

Tarantino, L.; De Stefano, Giorgio G.; Farella, N.; Perrotta, A.; Aloisio, V.; Tauchmanowa, L. 2000: US guided Percutaneous Ethanol Injection of cold nodules of the thyroid causing clinically evidence of neck mass. Journal of Endocrinological Investigation 23(6 Suppl): 38

Ginzberg, E. 1999: US health care: a look ahead to 2025. Annual Review of Public Health 20: 55-66

Fang, J.; Alderman, M.H. 2001: US hospitalization trend for congestive heart failure with hypertension - 1979-1997. American Journal of Hypertension 14(4 Part 2): 205A-206A

Gardner, J.W. 2004: US military casualties in Operation Iraqi Freedom. American Journal of Epidemiology 159(11, Suppl S): S76

Larson, T.; Utz, W.; Bruskewitz, R.; Mayer, R.; Blute, M.; Diokno, A.; Gibbons, R.; Wilson, J.; Kaplan, S. 1999: US multicenter study results of targeted transurethral thermo-ablation therapy for benign prostatic hyperplasia continues to show improvement in patients symptoms and flow rates without compromise in morbidity. Journal of Urology 161(4 Suppl): 389

Thamer, M.; Hwang, W.; Fink, N.E.; Klag, M.J.; Sadler, J.H.; Powe, N.R. 1999: US nephrologists choice of dialysis modality based on randomized hypothetical patient scenarios. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 257A

Cashore, B. 1999: US pacific northwest. Wilson, B, Cornelis van Kooten, G, Vertinsky, I, Arthur, L Forest policy: International case studies 47-79

Ault, A. 1999: US panel backs 24-hour glucose monitor. Lancet (North American Edition) 353(9155): 822

Mccarthy, M. 1999: US panel suggest changes in organ allocation. Lancet (North American Edition) 354(9176): 405

Troxell, T.C. 2000: US perspective on mycotoxin regulatory issues. Abstracts of Papers American Chemical Society 220(Part 1): AGFD 110

Hnizdo, E.; Sullivan, P.A.; Bang, K.M.; Wagner, G. 2002: US population prevalence, odds ratio and attributable fraction for airflow obstruction and employment by industry A study of NHANES III data. American Journal of Epidemiology 155(11 Suppl): S77

Klee, G.G. 2001: US proficiency testing Too little, too late?. Clinical Chemistry 47(S6): S24-S25

Walker, S.J. 2002: US regulations/FDA perspective. International Journal of Toxicology 21(6): 530

Gottlieb 1999: US reports increase in liver cancer. BMJ 318(7186): 755A

Cooney, C.M. 2004: U.S. rules are in step with other governments'. Environmental Science and Technology 38(13): 245a

Foletto, M.; Rossi, C.R.; Scagnet, B.; Tregnaghi, A.; Montesco, M.C.; Casara, D.; Lise, M. 2001: US scan and sentinel node biopsy in the diagnosis of nodal metastases in patients with melanoma. European Journal of Cancer 37(Suppl 6): S82

Hyde, W.F.; Stuart, W.B. 1999: US south. Wilson, B, Cornelis van Kooten, G, Vertinsky, I, Arthur, L Forest policy: International case studies 23-45

Hawkins, R.G.; Houston, M.C. 2004: US spending on diuretics directly predicts ESRD incidence changes in a time-lagged fashion. American Journal of Hypertension 17(5

Pirisi, A. 1999: US study reports poor management of elderly people with asthma. Lancet (North American Edition) 354(9184): 1100

Snydman, D.R.; Jacobus, N.V.; Mcdermott, L.A.; Finegold, S.; Harrell, L.; Hecht, D.W.; Jenkins, S.; Pierson, C.; Rihs, J.; Venezia, R.; Goldstein, E. 2001: US survey on the susceptibility of the B fragilis group using recent NCCLS criteria Comparison 1997-1999. International Journal of Antimicrobial Agents 17(Suppl 1): S116

Tanne, J.H. 1999: US survey reveals deficits in women's health care. BMJ 318(7195): 1374

Flores, A. 2004: US tick control specialists confer with Scottish counterparts. International Pest Control 46(3): 168-169

Carter,C.A.; Gunning-Trant,C. 2010: US trade remedy law and agriculture trade diversion and investigation effects. Canadian Journal Of Economics: 1, 97-126

Kruszon Moran, D.; Jumaan, A.; Seward, J.; Mcquillan, G. 2004: US trends in immunity to varicella in the age of vaccination NHANES III and NHANES 1999-2000. American Journal of Epidemiology 159(11, Suppl S): S32

Tanne, J.H. 1999: US trial of gene therapy for cystic fibrosis. BMJ 318(7191): 1096

Mckinley, J.C.Jr 1999: US unveils plan to aid 68 species in Everglades. New York Times 148(51527): A18

Friedland, B.; Mcgrory, C.E. 2001: US womens attitudes towards a potential vaginal microbicide. International Journal of STD and AIDS 12(Suppl 2): 192-193

Goodman, K.J.; O'rourke, K.; Mcpherson, S.; Wang, C.; Redlinger, T.; Campos, A.; De La Rosa, M. 2002: US-Mexico Cohort Study of Helicobacter pylori infection in children. American Journal of Epidemiology 155(11 Suppl): S43

Plowman, J.; Camalier, R.; Alley, M.; Sausville, E.; Schepartz, S. 1999: US-NCI testing procedures. Fiebig, H H Author, Burger, A M Author Contributions to Oncology; Relevance of tumor models for anticancer drug development 121-135

Caturelli, E.; De Sio, I.; Solmi, L.; Fusilli, S.; Roselli, P.; Fornari, F.; Andriuli, A.; Anti, M. 2003: US-guided fine-needle biopsy of early HCC Multicenter Italian Study. Journal of Hepatology 38(Suppl 2): 90

Goel, V.; Katz, S.; Anderson, G.; Gorey, K. 2001: US/Canada comparisons in health services Methodological issues and interpretation. American Journal of Epidemiology 153(11 Suppl): S14

Asano, S.; Honda, T.; Goshima, F.; Hashimoto, H.; Nishiyama, Y.; Miyake, Y. 1999: US3 protein kinase of herpes simplex virus type 2 plays a role in protecting neuronal cells from apoptosis induced by HSV-infection in the trigeminal ganglion. IOVS Investigative Ophthalmology and Visual Science 40(4): S255

McCarthy, M. 2002: USA moves quickly to push biodefence research. Lancet 360(9335): 732

Ault, A. 1999: USA starts to identify blood recipients at risk from hepatitis C. Lancet (North American Edition) 353(9165): 1686

Cohade, C.; Mourtzikos, K.A.; Wahl, R.L. 2003: USA-Fat Prevalence is dependent on ambient outdoor temperature. Journal of Nuclear Medicine 44(5 Suppl): 95P-96P

Eitzen, Edward, M.Jr 2000: USAMRIIDs role in the response to bioterrorism. International Journal of Toxicology 19(6): 18-19

Slusser, J.R.; Bigelow, D.S.; Neale, P.J. 1999: USDA UV-B radiation monitoring program. Photochemistry and Photobiology 69(SPEC ISSUE ): 80S

Jrafi 2000: USDA issues final rules on meat and poultry irradiation Backgrounders. Food Irradiation Japan 35(1-2): 73-76

Kulpa, J.A. 2000: USDA perspective on toxicology issues. International Journal of Toxicology 19(6): 21

Haytowitz, D.; Gebhardt, S.; Beecher, G.; Pehrsson, P.; Holden, J. 2004: USDA39;s National Food and Nutrient Analysis Program A Comparison Of Old and New Carotenoid Values. FASEB Journal 18(4-5): Abstract 124

Galizia, A. 2003: USEPAS response activities to the World Trade Center disaster. Toxicological Sciences 72(S-1): 185-186

Chen, N.; Szentirmay, M.; Yang, H.X.; Sawadogo, M. 2003: USF is an important repressor of prostate cancer cell proliferation and also mediates amino acid limitation-induced inhibition of cell proliferation. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1326

Kone, B.C.; Gupta, A.K. 2002: USF-1 and -2 trans-repress IL-1beta-induced iNOS transcription in mesangial cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 88A

Zhu, Y.; Vaulont, S.; Kanalas, J.; Sharma, K. 2000: USF-1 contributes to glucose-induced TGF-b1 gene activity. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 656A-657A

Manga, N.; Makaula, S.; Sack, M.N.; Essop, F. 2002: USF1 trans-activates the rat cardiac acetyl-CoA carboxylase gene A potential regulatory factor in response to nutritional flux. Circulation 106(19): II196

Williams, R.L. 2002: USP excipient monographs Opportunities and issues. International Journal of Toxicology 21(6): 529

Balogun, R.A.; Collins, A.J.; Kaplan, A.A. 2001: USRDS data for the fractional excretion of urea Implications for the initiation of dialysis as per DOQI guidelines. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 445A-446A

Louis, T.A.; Liu, J.; Pan, W.; Ma, J.Z.; Collins, A.J. 2001: USRDS methods for estimating and interpreting provider-specific standardized mortality ratios. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 224A

El-Jack, M.; Goldfarb, D.; Gill, I.; Flechner, S.; Streem, S.; Modlin, C.; Novick, A. 2002: USTVS survey of laporoscopic donor nephrectomy. Transplantation Proceedings 34(2): 729-730

Sorbera, L.A.; Rabasseda, X.; Castaner, J. 2001: UT-15 Treatment of pulmonary hypertension, treatment of peripheral vascular disease. Drugs of the Future 26(4): 364-374

Klein, J.D.; Doran, J.J.; Sands, J.M. 2003: UT-A abundance is increased in rat kidney cortex by a low protein diet. FASEB Journal 17(4-5): Abstract 333

Rouillard, P.; Klein, J.D.; Sands, J.M. 1999: UT-A protein abundance is altered in response to dietary protein in liver and kidney. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 24A

Smith, C.P.; Cooper, G.J.; Morris, I.D.; Fenton, R.A. 2001: UT-A urea transporter isoforms are expressed in testis. FASEB Journal 15(5): A852

Duchesne, R.; Klein, J.D.; Rouillard, P.; Bailey, J.L.; Lea, J.P.; Sands, J.M. 1999: UT-A urea transporter proteins in rat heart Regulation by uremia and angiotensin II. FASEB Journal 13(4 Part 1): A392

Klein, J.D.; Froehlich, O.; Smith, P.M.; Gunn, R.B.; Sands, J.M. 2004: UT-A1 is expressed in the apical membrane of stably transfected MDCK cells. FASEB Journal 18(4-5): Abstract 673

Kim, D.; Sands, J.M.; Gertner, R.A.; Klein, J.D. 2003: UT-A1 is upregulated by both diabetes mellitus and vasopressin in the Brattleboro rat. FASEB Journal 17(4-5): Abstract 333

Roberts, B.R.; Klein, J.D.; Gunn, R.B.; Sands, J.M. 2001: UT-A1 urea transporter regulation in lithium-treated rats. FASEB Journal 15(5): A852

Trinh Trang Tan, M.M.; Lasbennes, F.; Roudier, N.; Bailly, P.; Ripoche, P. 2001: UT-B protein isoforms in rat Tissular distribution and regulation by antidiuretic hormone in kidney medulla. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 23A

Lucien, N.; Lasbennes, F.; Roudier, N.; Cartron, J.P.; Bailly, P.; Trinh Trang Tan, M.M. 2002: UT-B urea transporter is widely distributed in murine tissues and downregulated by water deprivation in the bladder. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 68A

Matsumoto, T.; Takahashi, K.; Iwatsubo, E. 1999: UTI in neurogenic bladder. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 7

Ronald, A. 1999: UTIs in patients with diabetes. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 7

Fujita, H.; Fujihara, T.; Nakamura, M.; Nakata, K. 2001: UTP activates the extracellular-signal regulated kinase-1/2 signaling pathway in primary cultured conjunctival epithelial cells. IOVS Investigative Ophthalmology and Visual Science 42(4): S485

Johnson, R.S.; Chester, R.E. 2001: UTP allosterically regulates transcription initiation from the bacteriophage T7 A1 promoter by Escherichia coli RNA polymerase. FASEB Journal 15(5): A901

White, P.J.; Porter, K.; Kumari, R.; Boarder, M.R. 2000: UTP inhibits PDGF-BB mediated proliferation in human vascular smooth muscle cells. Journal of Submicroscopic Cytology and Pathology 32(3): 480

Klebingat, M.; Wirkner, K.; Illes, P. 2003: UTP potentiates P2X3 receptor-mediated currents in HEK293-hP2X3 cells by phosphorylation of the extracellular loop. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R36

Chaulet, H.; Pacaud, P.; Loirand, G.; Desgranges, C.; Gadeau, A. 2000: UTP promotes arterial smooth muscle cell migration The central role for osteopontin. Circulation 102(18): 2; 353

Palmer Densmore, M.; Deachapunya, C.; O'grady, S. 2002: UTP regulation of ENaC by PKC in endometrial epithelial cells. FASEB Journal 16(4): A54

Palmer Densmore, M.; Lee, S.Y.; O'grady, S. 2003: UTP-dependent Cl secretion across immortalized endometrial epithelial cells involves stimulation of calcium-activated Cl channels and CFTR. FASEB Journal 17(4-5): Abstract 803

Ueda, H.; Hosoya, K.I.; Shiue, M.H.I.; Kim, K.J.; Lee, V.H.L. 1999: UTP-induced net Cl- secretion in the pigmented rabbit conjunctiva is mediated by Ca2+ signaling mechanisms. IOVS Investigative Ophthalmology and Visual Science 40(4): S90

Inglis, S.K.; Waller, E.A.; Olver, R.E. 1999: UTP-mediated regulation of Cl- secretion and Na+ absorption in porcine tracheal epithelium. Journal of Physiology (Cambridge) 517P: 16P

Mengling, T.; Czisch, M.; Resch, T.; Broecker, E.B.; Pincelli, C.; Walczak, H.; Leverkus, M. 2001: UV B induced keratinocyte apoptosis requires the activation of mitochondrial signal transduction pathways but proceeds independent of caspases. Archives of Dermatological Research 293(1-2): 91

D.F.ria, D.L.A.; Constantino, V.R.L.; Dias, P.M.; Batchelder, D.N. 1999: UV Raman microscopy of porphyrins immobilized in inorganic matrices. Greve, J, Pupels, G J, Otto, C Spectroscopy of biological molecules: New directions 185-186

Kubicki, J.D.; Trout, C.C. 2002: UV Raman spectroscopy and ab initio calculations of carboxylic acids-Al solutions. Abstracts of Papers American Chemical Society 224(1-2): GEOC 12

Tsapin, A.I.; Storrie Lombardi, M.C.; Nealson, K.H.; Mcdonald, G.D. 1999: UV Resonance Raman spectroscopy of whole cells and its components. Abstracts of the General Meeting of the American Society for Microbiology 99: 573

Tsukroff, E.; Mukerji, I. 2001: UV Resonance Raman spectroscopy study of a DNA triple helix. Journal of Biomolecular Structure and Dynamics 18(6): 966-967

McGown, E.L. 2000: UV absorbance measurements of DNA in microplates. Biotechniques 28(1): 60; 63-64

Ellis, D.G.; Bos, M.A. 2000: UV absorbing compositions. Official Gazette of the United States Patent and Trademark Office Patents 1236(1)

Mukerji, I.; Williams, A.P. 1999: UV absorption and resonance Raman studies of a DNA dodecamer containing an A3T3 tract. Biophysical Journal 76(1 Part 2): A314

Wang, Z.; Wan, Y.; Voorhees, J.; Fisher, G. 1999: UV activates NF-01kappaB through an antioxidant-sensitive pathway that is independent of cytokines in human keratinocytes and skin in vivo. Journal of Investigative Dermatology 112(4): 561

Podstawczynska,A. 2010: UV and global solar radiation in odz, Central Poland. International Journal Of Climatology: 1, 1-10

Kim, W.K.; Lee, K.W.; Lee, S.J.; Kim, B.J.; Lee, H.Y.; Park, C.H.; Kim, D.S.; Choi, K.B.; Yoo, E.J. 2002: UV blocking and slimming cosmetic composition. Official Gazette of the United States Patent and Trademark Office Patents 1264(4)

Faubl, H. 2001: UV blocking lenses and material containing benzotriazoles and benzophenones. Official Gazette of the United States Patent and Trademark Office Patents 1247(2)

Cobb, J.K.; Bialozynski, C.; Neitz, J.; Jacobs, G.H.; Neitz, M. 1999: UV cone pigment genes from Syrian and Siberian hamsters. IOVS Investigative Ophthalmology and Visual Science 40(4): S353

Sievert, M.K.; Resek, J.F.; Wu, Z.; Rong, Y.; Ruoho, A.E. 2000: UV crosslinking of adrenergic receptors and ligands. Detection by SDS-PAGE. Methods in Molecular Biology 126: 315-327

Wedekamp, H. 2001: UV disinfecting device advantageous for fluids flows. Official Gazette of the United States Patent and Trademark Office Patents 1246(3)

Shimmura, S.; Tadano, K.; Shimazaki, J.; Tsubota, K. 2001: UV dose-dependent cell death expression in corneal epithelial cells. IOVS Investigative Ophthalmology and Visual Science 42(4): S889

Kosmadaki, M.; Noh, Y.; Yaar, M.; Detmar, M.; Gilchrest, B.A. 2003: UV down-regulates the angiogenesis inhibitor thrombospondin-1 in normal human keratinocytes. Journal of Investigative Dermatology 121(1): 0032

Rojas, S.; Davidson, E. 2001: UV effects on Ambystoma tigrinum virus. AAAS Annual Meeting and Science Innovation Exposition 167: A90, February 15-20

Peris, K.; Chimenti, S.; Fargnoli, M.C.; Valeri, P.; Kerl, H.; Wolf, P. 1999: UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas. Journal of Investigative Dermatology 112(5): 825-826

Mildner, M.; Mlitz, V.; Ballaun, C.; Gruber, F.; Tschachler, E. 2004: UV induced hepatocyte growth factor from dermal fibroblasts protects keratinocytes and fibroblasts from UV-induced apoptosis. Journal of Investigative Dermatology 123(2)

Ansel, J.C.; Abraham, T.A.; Zivony, A.S.; Edelhauser, H.F.; Armstrong, C.A.; Song, P.I. 2001: UV induces human corneal epithelial cell NF-kappaB activation and results in the production of proinflammatory cytokines IL-1, IL-6, IL-8 and TNFalpha. IOVS Investigative Ophthalmology and Visual Science 42(4): S575

Liu, M.; Wikonkal, N.M.; Brash, D.E. 1999: UV induces p21WAF1/CIP1 protein in keratinocytes without p53. Journal of Investigative Dermatology 113(2): 283-284

Kosmadaki, M.; Yaar, M.; Arble, B.; Gilchrest, B. 2002: UV induction of vascular endothelial growth factor independent of TNF-alpha. Journal of Investigative Dermatology 119(1): 332

Jiang, W.; Muller, H.K.; Ananthaswamy, H.N.; Kripke, M.L. 1999: UV irradiation augments lymphoid malignancies in mice with only one copy of p53. Proceedings of the American Association for Cancer Research Annual Meeting 40: 100

He, T.; Quan, T.; Voorhees, J.J.; Fisher, G.J. 2000: UV irradiation blocks cellular responses to transforming growth factor-beta through downregulation of its type-II receptor and induction of Smad7. Journal of Investigative Dermatology 114(4): 821

Krause, R.; Winter, P.; Mienert, K.; Dobberke, J.; Neumayer, H.H.; Roth, H.J.; Schmidt Gayk, H.; Buehring, M. 2001: UV irradiation during hemodialysis New treatment of vitamin D deficiency. Nephrology Dialysis Transplantation 16(6): A88

Park, H.Y.; Block, N.Y.; Gilchrest, B.A. 2000: UV irradiation increases the expression of PKC-beta. Journal of Investigative Dermatology 114(4): 882

Quan, T.; He, T.; Voorhees, J.; Fisher, G. 2001: UV irradiation inhibits procollagen synthesis by down-regulating the TGF-beta type-II receptor in human skin fibroblasts. Journal of Investigative Dermatology 117(2): 399

Costanzo, A.; Papoutsaki, M.; Bianchi, L.; Peris, K.; Levrero, M.; Chimenti, S. 2000: UV irradiation modulates p63 function in human keratinocytes by inducing phosphorylation of its DNA binding domain. Journal of Investigative Dermatology 115(3): 549

Hofmann Wellenhof, R.; Strunk, D.; Wolf, P.; Hubmer, M.; Legat, F.; Smolle, J.; Kerl, H. 2000: UV irradiation of human skin explants reduces migration of dendritic cells. Journal of Investigative Dermatology 114(1): 227

Tronnier, M.; Alexander, M.; Löntz, W.; Brinckmann, J. 2001: UV light does not induce p53 mutation in melanocytes in vitro. Dermatology 202(4): 339-340

Marr, D.; Shellman, Y.; Gendall, J.; Fujita, M.; Norris, D.A. 1999: UV light effects on apoptosis regulatory proteins, Bax and Bcl-2, in melanoma. Journal of Investigative Dermatology 112(4): 561

Biesalski, H.K. 2004: UV light induced HO1- and IL6-Gene expression is enhanced by Beta-carotene. FASEB Journal 18(4-5): Abstract 356

Burgess, L.C.; Hall, J.O. 1999: UV light irradiation of plastic reaction tubes inhibits PCR. Biotechniques 27(2): 252; 254-256

Tanaka, T.; Suzuki, J.; Yamakawa, N.; Usui, M. 1999: UV light-induced changes in the immunogenicity of alpha-crystalline. IOVS Investigative Ophthalmology and Visual Science 40(4): S141

Roth, J.; Broek, D.; Lymberis, S.; Brooks, P.C.; Formenti, S.C. 2001: UV mediated exposure of cryptic angiogenesis regulatory sites within collagen. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 238

Pinnell, S.R.; Lin, J.; Grichnik, J.; Selim, M.; Shea, C. 2002: UV photoprotection by topical vitamins C and E. Journal of Investigative Dermatology 119(1): 334

Robinson, Larry Richard 1999: UV protection compositions. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)

Blaustein, A.R.; Kiesecker, J.M. 2000: UV radiation and amphibians declines. AAAS Annual Meeting and Science Innovation Exposition 166: A33, February 17-22

Clauser, A.; Williamson, C.E. 2002: UV radiation and ephemeral pool ecosystems The dynamic role of canopy cover. Ecological Society of America Annual Meeting Abstracts 87: 100

Buccino, A.; Lemarchand, G.; Mauas, P. 2002: UV radiation and habitable zones. Origins of Life and Evolution of the Biosphere 32(5-6): 542

Swank, R.; Palaniappan, S. 2000: UV radiation and vapor-phase hydrogen peroxide sterilization packaging. Official Gazette of the United States Patent and Trademark Office Patents 1232(3)

Adams, N.L.; Foltz, K.R. 2001: UV radiation delays mitosis and dephosphorylation of cyclin dependant kinase 2 in sea urchin embryos. American Zoologist 41(6): 1377

Wedkamp, H. 2003: UV radiation device, especially for disinfecting liquids with reduced UV transmission. Official Gazette of the United States Patent and Trademark Office Patents 1270(3)

Cope, R.B.; Hartman, J.; Haschek, W.; Morrow, C.; Small, P. 2003: UV radiation enhances Mycobacterium ulcerans infection in a CrlIAF -hrBR hairless guinea pig model of Buruli ulcer disease. Toxicological Sciences 72(S-1): 119

Brown, D.B.; Peritz, A.E.; Gasparro, F.P.; Mitchell, D.L. 2000: UV radiation from sunlamps must be filtered for biological relevance. Journal of Investigative Dermatology 114(4): 883

Dahms, H.-U.; Lee, J.-S. 2010: UV radiation in marine ectotherms: molecular effects and responses. Aquatic Toxicology 97(1): 3-14

Dumic, J.; Lauc, G.; Flogel, M. 2000: UV radiation induces galectin-3 expression through both AP-1 and NF- B signaling pathways. Glycobiology 10(10): 1117-1118

Shankar, U.; Ray, R.S.; Mehrotra, S.; Hans, R.K.; Dwivedi, R.S.; Joshi, P. 2000: UV radiation initiated superoxide radicals , generation by photoreactive antibiotics. Proceedings of the American Association for Cancer Research Annual Meeting 41: 369-370

Maruyama, S.; Sakurai, Y. 2004: UV radiation treatment apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1285(3)

Bright, A.; Waas, J. 2001: UV reflectance, bill colour and territory defence in blackbirds. Advances in Ethology 36: 127

Niizeki, T.; Nagatomo, S.; Kitagawa, T.; Kohzuma, T. 1999: UV resonance Raman spectroscopic studies of a blue copper protein, pseudoazurin from Achromobacter cycloclastes IAM 1013. Journal of Inorganic Biochemistry 74(1-4): 248

Kneipp, J.; Balakrishnan, G.; Spiro, T.G. 2004: UV resonance Raman spectroscopic studies of hemoglobin structure and function at excitation wavelengths below 225 nm. Biophysical Journal 86(1): 248a

Tsukroff, E.; Mukerji, I. 2002: UV resonance Raman spectroscopy of a DNA triple helix. Biophysical Journal 82(1 Part 2): 125a-126a

Boyden, M.N.; Asher, S.A. 2000: UV resonance Raman studies of Betanova. Biophysical Journal 78(1 Part 2): 13A

Asher, S.A. 2003: UV resonance Raman studies of protein structure and dynamics. Abstracts of Papers American Chemical Society 225(1-2): COLL 75

Terakita, A.; Koyanagi, M.; Shichida, Y.; Kawano, E.; Kinugawa, Y.; Oishi, T.; Tamotsu, S. 2003: UV sensitive pigment in the pineal organ of the lamprey. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology 136B(3): 546

Angioni, E.; Lercker, G.; Frega, N.G.; Carta, G.; Melis, M.P.; Murru, E.; Spada, S.; Banni, S. 2002: UV spectral properties of lipids as a tool for their identification. European Journal of Lipid Science and Technology 104(1): 59-64

Campbell, K.J.; Chapman, N.R.; Perkins, N.D. 2001: UV stimulation induces nuclear factor kappaB DNA-binding activity but not transcriptional activation. Biochemical Society Transactions 29(6): 688-691

Hoffmann, K.; Kaspar, K.; Von Kobyletzki, G.; Stuecker, M.; Altmeyer, P. 1999: UV transmission and UV protection factor measured on split skin following exposure to UVB radiation - Correlation with the minimal erythema dose. Photodermatology Photoimmunology and Photomedicine 15(3-4): 133-139

Dummer, R.; Osterwalder, U. 2000: UV transmission of summer clothing in Switzerland and Germany. Dermatology 200(1): 81-82

Kunkel, H. 2002: UV treatment device with time delay of water flowing there through. Official Gazette of the United States Patent and Trademark Office Patents 1263(4)

Waschulewski, M.; Lunau, K.; Nelson, P.E.; Zamzow, J.; Parzefall, J.; Schlupp, I. 2002: UV vision in female mollies. Zoology (Jena) 105(Suppl 5): 11

Parra, J.M. 2003: UV water treatment apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)

Mcfeat, G.; Mcmillan, T.J. 1999: UV wavelength dependence of p53 induction. British Journal of Cancer 80(Suppl 2): 73

Ekesten, B.; Gouras, P. 2000: UV- and M-cone signals in single cells of murine retina and superior colliculus. IOVS Investigative Ophthalmology and Visual Science 41(4): S937

Koch, F.; Blumthaler, M.; Kaempgen, E.; Schuler, G.; Fritsch, P.; Romani, N. 2001: UV-A irradiation inhibits the T-cell stimulatory function of mature murine Langerhans cells. Journal of Investigative Dermatology 117(4): 1013

Asawanonda, P.; Khoo, L.S.; Fitzpatrick, T.B.; Taylor, C.R. 1999: UV-A1 for keloid. Archives of Dermatology 135(3): 348-349

Aguirre, V.; Mcgrath, H.Jr 2000: UV-A1 irradiation increases nitric oxide levels in patients with systemic lupus erythematosus. Journal of Investigative Medicine 48(1): 159A

Pancotto, V.; Sala, O.; Cabello, M.; Lopez, N.; Ballare, C.; Caldwell, M.; Scopel, A. 2002: UV-B affects decomposition and decomposers in a native ecosystem in Tierra del Fuego, Argentina. Ecological Society of America Annual Meeting Abstracts 87: 403-404